The Design and Synthesis of a True, Heterogeneous, Asymmetric Catalyst by Wan, Kam To
The Design and Synthesis of 
a True, Heterogeneous, Asymmetric Catalyst 
Thesis by 
KamToWan 
In Partial Fulfillment of the Requirements 
for the Degree of 
Doctor of Philosophy 
California Institute of Technology 
Pasadena, California 
1994 
(Submitted May 17th, 1994) 
11 
To my mom and dad 
111 
Acknowledgments 
I would like to thank the members of my committee, Professors Mark E. 
Davis, Harry B. Gray, Fred C. Anson, B. Vincent McKoy, and Dr. Jay A . 
Labinger for their time and interest in this work. 
I wish to express my sincere appreciation to my research advisor, Prof. 
Mark E. Davis for many insightful comments on my research and giving me 
complete freedom in my research work. I was also fortunate to have Prof. 
Harry B. Gray as my co-advisor. His support, related or not to my research 
has been enormous during my stay at Caltech. Special thanks also go to Prof. 
John E. Bercaw for helpful discussions on the rhodium system. 
Dr. Denis Forster is especially thanked for his generous gift of naproxen 
precursor. I would also like to thank all my colleagues in the Davis' group. 
And to my family and Elisa who supported me so much, I am 
especially grateful to them for their love and encouragement. Dr. M.C. Chu 
also deserves my special thanks for many meals and great coffees. 
lV 
Abstract 
This work describes the design and synthesis of a true, heterogeneous, 
asymmetric catalyst. The catalyst consists of a thin film that resides on a high-
surface-area hydrophilic solid and is composed of a chiral, hydrophilic 
organometallic complex dissolved in ethylene glycol. Reactions of prochiral 
organic reactants take place predominantly at the ethylene glycol-bulk organic 
interface. 
The synthesis of this new heterogeneous catalyst is accomplished in a 
series of designed steps. A novel, water-soluble, tetrasulfonated 2,2'-
bis(diphenylphosphino)-1,1'-binaphthyl (BINAP-4S03Na) is synthesized by 
direct sulfonation of 2,2'-bis(diphenylphosphino)-1,1 '-binaphthyl (BINAP) . 
The rhodium (I) complex of BINAP-4S03Na is prepared and is shown to be 
the first homogeneous catalyst to perform asymmetric reductions of prochiral 
2-acetamidoacrylic acids in neat water with enantioselectivities as high as 
those obtained in non-aqueous solvents. The ruthenium (II) complex, 
[Ru(BINAP-4S03Na)(benzene)Cl]Cl is also synthesized and exhibits a broader 
substrate specificity as well as higher enantioselectivities for the homogeneous 
asymmetric reduction of prochiral 2-acylamino acid precursors in water. 
Aquation of the ruthenium-chloro bond in water is found to be detrimental to 
the enantioselectivity with some substrates. Replacement of water by ethylene 
glycol results in the same high e.e's as those found in neat methanol. The 
ruthenium complex is impregnated onto a controlled pore-size glass CPG-240 
v 
by the incipient wetness technique. Anhydrous ethylene glycol is used as the 
immobilizing agent in this heterogeneous catalyst, and a non-polar 1:1 
mixture of chloroform and cyclohexane is employed as the organic phase. 
Asymmetric reduction of 2-(6'-methoxy-2'-naphthyl)acrylic acid to the 
non-steroidal anti-inflammatory agent, naproxen, is accomplished with this 
heterogeneous catalyst at a third of the rate observed in homogeneous 
solution with an e .e . of 96% at a reaction temperature of 3°C and 1,400 psig of 
hydrogen. No leaching of the ruthenium complex into the bulk organic phase 
is found at a detection limit of 32 ppb. Recycling of the catalyst is possible 
without any loss in enantioselectivity. Long-term stability of this new 
heterogeneous catalyst is proven by a self-assembly test. That is, under the 
reaction conditions, the individual components of the present catalytic system 
self-assemble into the supported-catalyst configuration. 
The strategies outlined here for the design and synthesis of this new 
heterogeneous catalyst are general, and can hopefully be applied to the 
development of other heterogeneous, asymmetric catalysts. 
Vl 




Table of Contents 
List of Figures 
List of Tables 
Chapter One Introduction and Objectives 
Chapter Two Asymmetric Hydrogenation in Water by a 
Rhodium Complex of Sulfonated-BINAP 
Chapter Three Ruthenium (11)-Sulfonated-BINAP: A Novel Water-
Soluble Asymmetric Hydrogenation Catalyst 




















List of Figures 
Chapter One 
Figure 1.1 Schematic diagram of supported aqueous-phase catalysis 13 
Chapter Three 
Figure 3.1 Reaction scheme for the reduction of prochiral substrates 35 
Chapter Four 




Figure 5.1 Reaction scheme for the reduction of substrate 1 to naproxen 89 
Figure 5.2 Schematic diagram of the new heterogeneous catalyst 90 
Vlll 
List of Tables 
Chapter Two 
Table 2.1 31p NMR data for various ligands and rhodium 
complexes 
Table 2.2 Hydrogenation of 2-acetamidoacrylic acids at room 
temperature under 1 atm H2 
Chapter Three 
Table 3.1 Asymmetric hydrogenation of 2-acylamino acid precursors 
and methylenesuccinic acid by water-soluble ruthenium 
(ll)-sulfonated-BINAP complex under 1 atm H2 
Table 3.2 Asymmetric hydrogenation of 2-acetamidoacrylic acid and 
2-acetamidocinnamic acid by water-soluble ruthenium 
sulfonated-BINAP catalyst in various water I methanol 
mixtures at room temperature and 1 atm H2 
Table 3.3 Pressure effect on the enantioselection for the asymmetric 
hydrogenation of 2-acylamino acid precursors and 
methylenesuccinic acid by water-soluble ruthenium (II) 
sulfonated-BINAP catalyst at RT 
Table 3.4 Effect of added triethylamine on the enantioselectivities for 
the asymmetric hydrogenation of methylenesuccinic acid and 
methyl-2-acetamidoacrylate by water-soluble ruthenium 









Table 4.1 Homogeneous, asymmetric hydrogenation of 2-(6'-methoxy-
2'-naphthyl)acrylic acid by [Ru(BINAP-4S03Na)(benzene)]2+ 
complex in methanolic solvents at room temperature 67 
Table 4.2 Two-phase, asymmetric hydrogenation of 2-(6'-methoxy-2'-
naphthyl)acrylic acid by [Ru(BINAP-4S03Na)(benzene)]2+ 
complex in 1:1 ethyl acetate/water solvent mixture at RT 68 
Table 4.3 Heterogeneous, asymmetric hydrogenation of 2-(6'-methoxy-
2'-naphthyl)acrylic acid by SAP-Ru-BINAP-4S03Na catalyst 
in ethyl acetate 
Table 4.4 Catalytic activity as a function of water content in the 
heterogeneous, asymmetric hydrogenation of 2-(6'-methoxy-
2'-naphthyl)acrylic acid by SAP-Ru-BINAP-4S03Na catalyst 
in ethyl acetate 
Chapter Five 
Table 5.1 Homogeneous reduction of substrate 1 
Table 5.2 Activities of various catalytic systems in the reduction of 
substrate 1 
Table 5.3 Enantioselectivities in the reduction of substrate 1 as a 
function of ethylene glycol content in the organic phase 
Table 5.4 Ruthenium leaching as a function of ethylene glycol content 
in the reduction of substrate 1 
Table 5.5 Enantioselectivities in the reduction of substrate 1 with 










Introduction and Objectives 
2 
INTRODUCTION 
Organic synthesis involves the ability to direct a reaction strictly along 
a single desired chemical channel (chemoselectivity) and to dictate a specific 
point of attack by the reagent (regioselectivity) under conditions as mild as 
possible. In asymmetric synthesis, apart from the solution to these problems, 
the reaction must be directed toward the formation of one specific absolute 
configuration. 
Living organisms are naturally chiral and so their biochemical 
metabolisms are subjected to the effects of chirality. Their chiral enzymes and 
receptors can interact in different ways with the two enantiomeric forms of a 
biologically active substrate - this applies to drugs and food additives, to 
pheromones, and to insecticides. The difference in the acceptance of the 
stereoisomeric forms of bioactive compounds into the body can be extremely 
substantial, and consequences of such differences are not always harmless (1-
3). 
The enantiomers of an bioactive compound introduced into the 
organism can show their effects at various stages and in various forms: during 
transport and absorption processes in cells; during the binding of inhibitors to 
enzymes and of agonists or antagonists to receptors; during distribution 
between various tissues. Stereoselectivity in the biochemistry of metabolism 
can show up both in the rates and the directions of biotransformation ( 4,5) . 
3 
They are attributed to the stereospecific interactions of living organism with 
pharmaceutical products and food and flavor additives, and of plants and 
insects with various agents used for the protection of plants. Thus, for 
example, the difference in the binding of the two enantiomers or 
diastereomers with the respective receptors amounts to 1,000-fold in the case 
of beta blockers (6) and increases to 10,000-fold in the interaction between 
anticholinesteric products and muscarine receptors (7,8). During the in vivo 
metabolism, the (R)-enantiomer of ibuprofen (the well-known non-steroidal 
anti-inflammatory product of the "profen" group (9)) isomerizes to the (S)-
form, whereas such transformations do not occur with the (S)-enantiomer (10) . 
Only the (R)-enantiomer of nicotine undergoes metabolic N-methylation 
under the influence of the respective enzyme, and (S)-nicotine, while not 
participating in such a process itself, greatly inhibits the reaction for the (R)-
form (4). 
With pharmaceutical products, one enantiomer (eutomer) can have a 
substantially stronger therapeutic effect than the other less active enantiomer 
(distomer); in the extreme case of complete inactivity can be regarded as a 
contaminant in the drugs (11 ). Thus, for example, the activity of most 
"profens" lies in the (S)-enantiomers, and the ratio of the activity of the 
eutomer and distomer in vitro amounts to 878 in the case of flurbiprofen 
(10,12-13). Only the (+)-form of estrone gives a hormonal effect, whereas the 
(-)-form does not exhibit any hormonal activity (1) . It is therefore obvious that 
the use of such products in the enantiomerically pure form can reduce the 
dose and, consequently, the stress on the organism. Sometimes, the two 
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stereoisomers of the same drug can have qualitatively different therapeutic 
effects. For instance, the (2R,3S)-isomer of propoxifen is used under the name 
"Darvon" as an analgesic product, whereas the (2S,3R)-enantiomer of the same 
compound is known as the anticough drug "Norvad" (12). The intake of a 
racemic drug with two different therapeutic effects is of course rarely 
desirable. In the extreme case that the distomer inhibits the action of the 
eutomer, the admission of the enantiomerically pure form greatly improves its 
therapeutic effect. 
The strongest argument in favor of the use of enantiomerically pure 
drugs is the stereoselectivity found in the toxicological effects. There are a 
number of barbiturates where only one enantiomer exhibits a narcotic effect 
whereas the other enantiomer causes rise to convulsions (1). Of the two 
enantiomers of penicillamine only one has a useful antiarthritic effect, while 
the other one is highly toxic (14). The tragic story of the use of racemic 
thalidomide in therapeutic practice is well known. Here only the (-)-form is a 
powerful tranquillizer, whereas the (+)-form causes strong teratogenic effects 
(15,16) . This last example has perhaps been the most menacing warning about 
the dangers of neglecting the stereochemistry in the therapeutic practice of 
pharmaceutical drugs. 
Stereochemistry also plays an important in perfumery and food 
industry. It is known that one of the enantiomers of limonene has a lemon 
flavor while the other has an orange flavor; one of the stereoisomeric carvones 
smells of caraway while the other smells of menthol oil (14). There can also be 
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substantial differences in the taste perception and metabolism of the 
enantiomeric forms . For instance, (-)-asparagine has a bitter taste, while the 
(+)-isomer is sweet; the lysine used as an additive in certain animal foods is 
only assimilated in the (-)-isomer (1). Both the enantiomers of saccharose are 
perceived as identically sweet, but only the (+)-isomer is assimilated. Thus, the 
(-)-isomer can be used for dietary purposes (14). 
Large quantities of bioactive chemical agents are used for the protection 
of plants (17) . Herbicides and fungicides are used to suppress the growth of 
weeds and fungal diseases; plant hormones (18) regulate the growth and 
development of plants; insecticides and pheromones help control the 
population of insects (19) . However, issues that involve the conservation of 
ecology requires their uses in maximum effectiveness with minimum strain on 
the environment (20-22). The interaction between the chemical agents used for 
the protection of plants and the living organism is the same as in the 
pharmaceutical products mentioned above. Cases where the active agent is 
concentrated predominantly in one of the stereoisomers are not uncommon. 
Thus, for example, the activity of herbicides of the phenoxypropionic acid 
type is due almost exclusively to the (+)-forms (19,23); as a rule herbicides that 
operate by the inhibition of photosynthesis is more active in the (S)-form (24). 
The biochemical and toxicological characteristics of organophosphorus 
pesticides, herbicides, and plant growth regulators vary by three to five orders 
of magnitude, depending on the absolute configuration of the phosphorus 
atom (25-27). The use of such products in the enantiomerically pure form 
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makes it possible to reduce the dose by half, and consequently, to reduce the 
strain on the environment. 
Finally, there are situations where both stereoisomers of the same 
agrochemical agent have fundamentally different types of activity. The 
product paclobutrazole in the (2R,3R) configuration has high fungicidal 
activ ity, while its (25, 35)-enantiomer is a powerful herbicide (12); it is clear 
that if the protective function of the product is required, the herbicidal activity 
is extremely undesirable. Similar dualism is found in one of the acylalanine 
products CGA 29212; its (R)-form is proved to an excellent fungicide, whereas 
the (S)-form has strong herbicidal activity and has almost no fungicidal 
activity (28). 
These examples show that change in the absolute configuration of the 
same functional groups in the molecule can have just as significant 
consequences as a change in the chemical nature of the groups. The two 
stereoisomers must therefore be treated as two different chemical substances 
when assessing their biological activity. Consequently, a pharmaceutical 
product marketed in the racemic form must be regarded as a mixture of two 
compounds or as a drug contaminated to the extent of 50% (3,11) . 
Before 1982, of all the synthetic pharmaceutical products, 40% were 
chiral compounds; and of these only 12% were produced in the optically pure 
form (12,29). By 1987 the proportion of enantiomerically pure synthetic drugs 
has increased to 26% (30,31); it is presumed that toward the end of the century 
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up to 80% of chiral synthetic drugs will be produced in the optically pure form 
(30,32). However, today more than 500 synthetic chiral drugs are marketed in 
the racemic form (33). 
It is likely that in the near future most countries will adopt legal 
standards regulating the conditions for the production of drugs containing 
stereogenic centers. The Food & Drug Administration has already requested 
that new drug applications provide selected information on individual 
isomers in a mix. 
The traditional multi-step synthesis of a racemic mixture followed by 
resolution has been widely used for obtaining single enantiomers from a 
racemate. Classical resolution uses a second optically pure resolving agent to 
form diastereoisomeric salts. These diastereoisomeric derivatives, which differ 
in energy and physical properties, are then separated by crystallization. This 
method is unavoidably laborious, may introduce toxic impurities into 
pharmaceuticals and does not work for all chiral compounds. The 
diastereomeric interactions that make classical resolution possible are also 
exploited in chiral chromatography columns where the stationary phase 
contains an optically pure molecule that interacts differently with each of the 
components of a racemate. Though this technique is well suited to analytical 
separations, it is very difficult and expensive to scale up for large batches of 
synthetic drugs. Because of the high cost associated with the resolution 
process (low yields per cycle (<50%), and requires recycling of large amounts 
of resolving agents as well as the racemization of the unwanted enantiomer) 
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simple and economical processes for the direct production of pure 
enantiomers are highly desirable. 
Of all the possible methods for creating optically active molecules 
(chemical or enzymatic separation of racemates, transformation of natural 
chiral compounds, asymmetric synthesis from prochiral substrates, chemo- or 
biocatalytic synthesis), homogeneous, enantioselective catalysis by metal 
complexes is one of the most versatile and effective methodologies for 
asymmetric synthesis. Metal complexes with chiral organic ligands have been 
shown to act catalytically and multiply chirality (34) . These organometallic 
catalysts are neither symmetrical or flat, but they are endowed with 
functionality and chirality which allow differentiation of diastereomeric 
transition states with accuracy of 10 kJ/mol. Such molecular catalysts not only 
accelerate reactions of associated substrates, but they also control the 
stereochemical outcome of reactions in an absolute sense. The advantages of 
this type of catalyst when compared to catalysis by optically active organic 
compounds and enzymatic catalysis is the great flexibility of the metal 
complex catalysts. Both the chiralligand and the metal center can be varied for 
different organic transformations. 
The first catalytic, asymmetric reaction of prochiral compounds 
mediated by soluble chiral metal complexes was reported in 1966 (35). A chiral 
Schiff base-Cu (II) complex was found to catalyze the enantioselective 
carbenoid reaction between styrene and ethyl diazoacetate to give cis- and 
trans-2-phenylcyclopropanecarboxylates in <10% enantiomeric excess (e.e.). 
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Since then, homogeneous, enantioselective metal complex catalysis has 
achieved truly remarkable results over the short history of its development. 
More recent advances have generated a number of impressive homogeneous 
catalysts that have greatly raised the potential of chemical synthesis for 
bioactive substances. Enantioselectivities of over 95% e.e.'s are not uncommon. 
Large amounts of chiral compounds can now be produced that have natural 
and unnatural configurations with the use of only a very small quantity of a 
selected chiral source. 
It has been recognized for quite some time that one of the shortcomings 
of homogeneous catalysis is the obvious need for separating the catalyst from 
the product phase. The processes necessary to achieve the desired separation 
usually include thermal operations such as distillations, and these operations 
normally lead to thermal stresses on the catalyst. During the separation, the 
treatments can cause decomposition reactions and progressive deactivation 
during the lifetime of the catalyst. Furthermore, thermal separation processes 
seldom give quantitative recovery of the catalyst. 
Some progress has been made in the synthesis of asymmetric, 
heterogeneous catalysts, but to the author's knowledge not a single 
commercial chiral synthesis is achieved by a heterogeneous catalyst. One 
approach to the preparation of heterogeneous catalysts involves attachment of 
a homogeneous catalyst onto a suitable support. Cation-exchange resins and 
polymers are among the most widely used supports (36-41). In general, the 
immobilized catalysts never approach the combined 
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activity I enantioselectivity performance levels of their homogeneous 
counterparts and tend not to retain the metal complexes for significant lengths 
of time (42). A second way of solving the problem of separating the product 
and the catalyst involves modifying the latter with suitable hydrophilic 
groups, e.g., sulfonate or quaternary ammonium, that make it possible to 
transfer the catalyst into the aqueous phase, leaving the product in the organic 
phase, i.e., two-phase system (43-45). Product separation is simpler for two-
phase systems incorporating water-soluble catalysts. The hydrophilic catalyst, 
which is insoluble in the organic-phase is molecularly well defined like 
conventional homogeneous catalysts. These catalysts accomplish the 
asymmetric catalytic reaction in the aqueous-phase or at the phase boundary, 
and are removed from the desired product at the end of the reaction by a 
simple phase separation. Thermal separation processes, which can have 
detrimental effects on the active lifetime of the catalyst, are thereby avoided. 
Because of the high polarity of the water-soluble catalyst and its insolubility in 
the organic phase, leaching of the water-soluble catalyst into the organic-
phase is often below the detection limit. Unfortunately, the reaction rates 
achievable with two-phase systems are strongly dependent on the polarity of 
the substrate and/ or the limiting interfacial area between the two phases. In 
general, the reaction activities are orders of magnitude less active than the 
homogeneous catalysts (48). However, it is the poor enantioselectivity that 
really hinders the application of two-phase systems in asymmetric catalysis. 
Usually, poor enantioselectivities are found in aqueous media (47,49-53). 
Hence, new genuine heterogeneous, asymmetric catalysts have yet to be 
developed for practical asymmetric synthesis of optically pure compounds. 
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OBJECTIVES 
The objective of this research is to develop a heterogeneous, 
asymmetric, hydrogenation catalyst. The criteria for a successful 
heterogeneous asymmetric catalyst are that the catalyst has high activity and 
enantioselectivity without leaching of the active material into the product 
phase. Using these targets, we set out to design a true, heterogeneous, 
asymmetric catalyst. We began by using the concept of supported aqueous-
phase catalysis (SAPC) (54). The reasons for choosing this starting point for 
the design are that SAPC has been proven to provide very active and selective 
heterogeneous analogues to known homogeneous catalysts (55-57). These 
catalysts are designed to facilitate chemical reactions at the interface of two 
immiscible liquids. They consist of a very water-soluble organometallic 
complex dissolved in a film of water which is supported on a high-surface-
area hydrophilic solid. Reactions of liquid-phase organic reactants take place 
at the water-organic interface (Figure 1.1). Immobilization of the catalyst is 
accomplished through the use of a highly water-soluble ligand. 
The first stage of this work involved the synthesis of a highly water-
soluble, chiral diphosphine ligand. Because of the wide range of highly 
enantioselective reactions that have been achieved using organometallic 
catalysts with the 2,2'-bis(diphenylphosphino)-1,1'-binaphthylligand (BINAP) 
(58,59), BINAP was chosen as the model chiral diphosphine for water-
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solubilization. The development of the novel, heterogeneous, asymmetric, 
hydrogenation catalyst was divided into five stages, 
I. Synthesis of a water-soluble sulfonated-BINAP ligand (60) . 
II. Homogeneous, asymmetric catalytic studies with a rhodium 
sulfonated-BINAP complex (60) . 
III. Homogeneous, asymmetric catalytic studies with ruthenium 
sulfonated-BINAP complexes (61). 
IV. Development of a supported aqueous-phase asymmetric catalyst 
using the ruthenium catalyst for the asymmetric synthesis of 
naproxen (62). 
V. Development of a new heterogeneous, asymmetric catalyst for the 
asymmetric synthesis of naproxen (63). 
Stages I and II are described in chapter two, while stages III, IV and V 
are described in chapters three, four and five, respectively. 
13 
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CHAPTER TWO 
Asymmetric Hydrogenation in Water by a 
Rhodium Complex of Sulfonated-BINAP 
[Wan, K.T., and Davis, M.E., J. Chern. Soc., Chern. Commun. 1262, 1993] 
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Abstract: 
The synthesis of sulfonated 2,2'-bis(diphenylphosphino)-1,1 '-
binaphthyl (BINAP) is reported; a rhodium complex of this ligand is the first 
to perform asymmetric hydrogenation in neat water with optical yields as 
high as those obtained in non-aqueous solvent. 
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There is an increasing interest in the synthesis and application of water-
soluble organometallic catalysts (1) . The water solubilization of known 
organometallic catalysts is typically performed by incorporating highly polar 
functional groups such as amino, carboxylic acid, hydroxide or sulfonate into 
phosphine ligands (1) . In addition to the advantages of being able to use an 
environmentally benign solvent, water-soluble complexes can be employed in 
various configurations, e.g., organic-aqueous two-phase (1c,2), supported 
aqueous-phase (3), in order to achieve effective catalyst immobilization. Here, 
we report the synthesis of a new water-soluble ligand, sulfonated 2,2'-
bis(diphenylphosphino)-1,1 '-binaphthyl (4) and its use in the rhodium-
catalyzed asymmetric hydrogenation of prochiral olefins. 
The sulfonation of (R)-BINAP requires specific reaction conditions to 
eliminate the formation of phosphine oxides and to achieve a high yield of a 
single phosphine species. The sulfonation of (R)-BINAP was accomplished by 
dissolving (R)-BINAP (1g) in concentrated sulfuric acid (3.5 ml) with 
subsequent dropwise addition of 15 ml (during 2-3 hours) of fuming sulfuric 
acid ( 40 wt% sulfur trioxide in concentrated sulfuric acid) and stirring for 3 
days at 10°C under argon. The reaction was quenched by pouring the solution 
into 100 ml of ice-cooled water and the product neutralized by dropwise 
addition of aqueous sodium hydroxide (50 wt% NaOH) until a pH 7 was 
reached. The volume of the solution was reduced to 30 ml in vacuo and 
methanol (100 ml) added to precipitate any sodium sulfate present. 
Sulfonated-BINAP was recovered as solid by vacuum drying the filtered 
methanolic solution. The product was then purified by re-dissolving in neat 
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methanol, filtered and vacuum dried. Elemental analysis (Galbraith Lab., 
Knoxville, TN) of the recovered solid is consistent with the sample containing 
about 85% tetrasulfonated BINAP [calculated for BINAP-4S03Na : S/P: 
Na/ P :C/Na = 2:2:11; found, S/ P: Na/P:C/Na = 2.34/2.02/11 .31] . This result 
is in agreement with the 31p NMR spectrum that shows a single major 
resonance at o"" -11.1 with a second small peak around o = -12.7 (relative 
intensities are 86:14). The 33s NMR spectrum of the oxidized form of this 
sample (in D20) indicates that no sodium sulfate is present, to at least the 
detection limits of NMR (150,000 scans employed) and that no further 
information on the sample composition is possible because the sulfonate 
groups on the BINAP give a broad peak around o = -13 (relative to 
ammonium sulfate). Because of the difference in rr-stabilization energy, the 
phenyl rings in BINAP are relatively more reactive towards electrophilic 
aromatic substitution by sulfur trioxide as compared to the naphthyl rings. 
Thus, we speculate that in the major species obtained, only the four phenyl 
rings in the BINAP are sulfonated under the conditions described above. 
Otherwise, at least two distinct signals with equal intensities should appear in 
the 31p NMR spectrum. Although definitive assignments are not yet possible 
owing to the complexity of the 1 H and 13c NMR spectra, our NMR data are 
consistent with the premise that only the four phenyl rings are sulfonated in 
the major species obtained in 85% abundance. The remaining species is likely 
to be penta- or hexa-sulfonated BINAP with one or two extra sulfonated 
group(s) on the naphthyl ring(s) . As the origin of chiral recognition is 
attributed to the interaction of the four phenyl rings and the substrate, the 
presence of any extra sulfonated groups on the naphthyl rings is unlikely to 
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affect the enantioselectivity. In fact, similar activity and selectivity are found 
with catalysts prepared from several batches of ligand with different ratios of 
major to minor species (vide infra) . 
The rhodium sulfonated-BINAP catalyst was prepared as follows. 
[Rh(cod)Cl]2 (cod= cycloocta-1,5-diene) was treated with 2 equiv. of BINAP-
4S03Na in water at room temperature with an excess of sodium perchlorate. 
The cationic species, [Rh(BINAP-4S03Na)(cod)](Cl04), is formed and 
contacted with one atmosphere of dihydrogen to give the active catalyst 
[Rh(BINAP-4S03Na)(H20)2]+. Further addition of 2 equiv. of BINAP-
4S03Na or initial mixing of 4 equiv. with [Rh(cod)Cl]2 gives the inactive 
complex [Rh(BINAP-4S03Na)2]+. Assignments of these species are based on 
the data in Table 2.1. 
Asymmetric hydrogenations of 2-acetamidoacrylic acid (substrate 1) 
and its methyl ester (substrate 2) were conducted at room temperature and 
one atmosphere of dihydrogen in batch autoclaves. The conversion was 
measured by lH NMR spectroscopy and the enantiomeric excess (e.e.) 
determined by gas chromatography using a J. & W. Scientific CDX-B chiral 
capillary column after derivatization of the reaction products (6). 
Table 2.2 shows the results of hydrogenating 2-acetamidoacrylic acid 
and its methyl ester using the water-soluble rhodium complex with BINAP-
4S03Na. Like the non-sulfonated version of the rhodium BINAP catalyst, the 
enantioselection favors the (S)-enantiomers (4b). However, we do not observe 
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a dependence of e.e.'s on the concentration of substrate as is reported for the 
non-sulfonated rhodium-BINAP catalyst (4b). The e.e . is found to be 58±1% 
for substrate 1 in MeOH solvent over a substrate concentration range of 0.003-
0.078 M, 49±2% for substrate 2 in MeOH solvent over a substrate 
concentration range of 0.007-0.134 M and 68±1% for substrate 2 in H20 
solvent over a substrate concentration range of 0.007-0.039 M. Note that the 
results in Table 2.2 illustrate that the e.e. in pure water is approximately the 
same as observed with the non-sulfonated rhodium-BINAP catalyst in ethanol 
(70.4-68.0% vs . 67.0% (4b)). This is the first example of asymmetric 
hydrogenation in neat water where the optical yield obtained is as high as that 
observed in non-aqueous solvents. Normally, large losses in enantioselectivity 
are observed when water is used as solvent (2b,8). Additionally, loss in 
enantioselectivity is also reported with sulfonation of phosphine ligands 
(8a,d) . Here, not only are high enantioselectivities retained upon sulfonation 
and uses in neat water, the e.e.'s obtained with the rhodium sulfonated-
BINAP catalyst increases with the proportion of water in the solvent; the e.e. 
is 70.4% in pure water compared to 58.0% in neat methanol. The trend 
observed with 2-acetamidoacrylic acid (substrate 1) is also found with methyl-
2-acetamidoacrylate (substrate 2). 
We attempted a comparison between the hydrogenation behavior of 
non-sulfonated and sulfonated-BINAP rhodium complexes in ethanol. A 
direct comparison between these two complexes is not possible in water 
because non-sulfonated BINAP is not soluble in water. Also, the non-
sulfonated complexes prepared here or purchased from Aldrich gave very 
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low e.e.'s under one atmosphere of dihydrogen pressure as compared with 
that reported under four atmospheres (4b). Because of this, we are only able to 
compare initial turnover frequencies in water and ethanol for the sulfonated-
BINAP catalyst (Table 2.2). The activity of the rhodium sulfonated-BINAP 
ca tal ys t in neat water ( 45 hr-1) is only 6 to 7 times less active than that in neat 
ethanol (302 hr-1 ). The solubility of dihydrogen in ethanol and water at 25°C 
at 1 atm is 38.2x1o-4 and 8.53x1o-4 mol/1, respectively (9).Thus, the loss in 
initial turnover frequency when water is used as solvent is most likely due to 
the lowering of the dihydrogen solubility. The cause of the low e.e . in the non-
sulfonated system is unclear but catalyst decomposition is likely since a black 
precipitate appeared during the course of one of the reactions. 
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Table 2.1 31 P NMR data for various ligands and rhodium complexes 
Compound Solvent & (ppm)a 1JRh-P/Hz 
BINAP-4S03Na (L1) D20 -1l.O(s) 
[Rh(L1)(cod)]Cl04 020 31.0 (d) 144 
[Rh(L1 )(D20)2]Cl04 020 51.0 (d) 196 
(S)-BINAP (L2) C6D6-CD30D (4:1) -12.8 (s) # 
[Rh(L2)(nbd))Cl04 b CD30D 25.1 (d) 156# 
[Rh(L2)(MeOH)2]Cl04 CD30D 53.1 (d) 206# 
(S,S)-Cyclobutanediop-4S03Na (L3)c 020 -20.2 (s) -- :j: 
[Rh(cod)Cl]2 + (L3) D20 20.2 (d) 144:1: 
[Rh(L3)(H20)2]+ 020 43.5 (d) 182:1: 
(S,S)-BDPP-4S03Na (L4)d 020 0.7 (s) -- :j: 
[Rh(cod)Cl]2 + L4 020 29.3 (d) 144:1: 
[Rh(L 4)(H20)2]+ D20 53.2 (d) 185:1: 
a: 31 P NMR chemical shifts relative to H3P04; downfield shifts are positive. 
b: nbd = norbomadiene. 
c: (S,S)-Cyclobutanediop = (S,S)-1,2-bis( dipheny lphosphinomethyl)-cyclobutane. 
d: BDPP = bis(2-diphenylphosphinoethyl)(phenyl)phosphine. 
#: ref. 4(b) 
:j:: ref. 5 
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Table 2.2 Hydrogenation of 2-acetamidoacrylic acids at room temperature 
under 1 atm H2 
Substratea Solvent [Substrate]/ Substrate / e.e. (%)b 
mol r-1 catalyst 
1 H20 0.007 25 70.4, 68.0 
1 7:1 H20/ MeOH 0.017 40 67.0 
1 1:1 H20/ MeOH 0.017 41 56.0 
1 1:2 H20/ MeOH 0.042 75 55.0 
1 MeOH 0.017 40 58.0 
1 EtOH 0.017 41 58.6 
1 EtOH 0.031 76 35.oe,f(264)d 
1 1:1 EtOH/ THF 100 67.og 
2 H20 0.017 75 68.5, 68.3C 
2 H20 0.039 76 69.0(41)d 
2 H20 0.039 76 68.0C(45)d 
2 4:1 H20/ MeOH 0.017 76 61.2 
2 MeOH 0.017 75 47.8 
2 EtOH 0.031 75 56.0(302)d 
2 EtOH 0.031 76 2o.oe,h(389)d 
2 EtOH 0.031 76 22.oe,f(467)d 
a: substrates: 1, CH2=C(NHAc)COOH; 2, CH2=C(NHAc)COOMe 
b: 100% conversion and mainly (S) product configuration 
c: repeated experiments with different ligand syntheses and/ or reaction runs 
d: initial turnover frequency (hr-1) 
e: [Rh{(R)-BINAP}(solvent)2]Cl04 as catalyst 
f: synthesized here 
g: [Rh{(R)-BINAP}(solvent)2]+ as catalyst and at 4 atm H2 (ref. 4b) 
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CHAPTER THREE 
Ruthenium (H)-Sulfonated BINAP : 
A Novel Water-Soluble 
Asymmetric Hydrogenation Catalyst 
[Wan, K.T., and Davis, M.E., Tetrahedron : Asymmetry Vol. 4, No. 12, pp. 2461-2468, 1993] 
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ABSTRACT 
Ruthenium (11)-sulfonated-BINAP has been synthesized and this novel 
water-soluble complex is shown to be an excellent asymmetric hydrogenation 
catalyst for 2-acylamino acid precursors and methylenesuccinic acid in both 
methanolic as well as in neat water solvent systems. Enantiomeric excesses 
approaching 90% have been obtained in aqueous and methanolic solvents. 
Effects of solvent, pressure and the addition of organic base on 
enantioselectivity are described. 
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INTRODUCTION 
One of the most recent advances in asymmetric synthesis is the use of 
water-soluble organometallic catalysts (1,2). Numerous water-soluble, chiral 
phosphines have been used as ligands for transition-metal-catalyzed 
asymmetric syntheses in aqueous-organic two-phase solvent systems (3-6). 
For asymmetric hydrogenation, chiral sulfonated di-tert-phosphines have 
been the most widely used in preparing water-soluble catalysts (7,8). Thus far, 
highly stereoselective two-phase hydrogenations have been achieved almost 
exclusively with Rh (I)-based complexes (3-5, 9-11). Although, most of these 
water-soluble rhodium (I) complexes are very active catalysts, they are in 
general less robust than ruthenium catalysts. Also the variety of Rh (I)-
catalyzed reaction is not wide. Several studies have led to the conclusion that 
the double-bond geometry and, with some exceptions, the presence of the 2-
acyl amino group is obligatorily important for chiral efficiency (2). In view of 
the general synthetic significance of asymmetric hydrogenation, development 
of water-soluble chiral catalytic systems that are able to reduce a wider range 
of substrates has long been desired. 
Catalytic, asymmetric hydrogenation by means of a large variety of 
rhodium complexes with chiral ligands such as DIOP (12), BPPM (13), 
CHIRAPHOS (14), etc., has been extensively used to achieve high 
enantioselectivity. In contrast, there are relatively few reports on 
corresponding ruthenium complexes (15). With the advent of the outstanding 
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performance of various ruthenium-BINAP complexes (16), several preparation 
methods for mononuclear ruthenium catalysts in non-aqueous media have 
been devised (17-24). However, to our knowledge, no such methods have been 
developed for water-soluble ruthenium complexes. In fact, no water-soluble 
ruthenium chiral diphosphine catalysts have ever been reported in the 
literature. We have described earlier preliminary results concerning the use of 
a Rh (I)-sulfonated BINAP complex as an asymmetric hydrogenation catalyst 
in water (25). We now report the synthesis of a novel Ru (H)-sulfonated 
BINAP complex and its use in asymmetric hydrogenation with aqueous 
solvent. This ruthenium catalyst reveals superior enantioselectivity and 
stability when compared to the corresponding rhodium analogue. 
RESULTS AND DISCUSSION 
Catalyst Preparation 
From a practical standpoint, it is of interest to devise a one-step 
synthesis with water. When [Ru(benzene)Cl2]2 (0.0037g) is reacted with 
BINAP-4S03Na (0.0182g) [details concerning the preparation and 
characterization of this ligand can be found elsewhere (25)] in 5 ml water at 
55-60°C for 2 hours, a complex revealing a 31p NMR spectrum with two peaks 
in strictly 1:1 ratio [31p NMR (D20): D = 57.5 and 63.7 ppm] is formed. From 
the difference in line shape, the two resonances appear to be originated from 
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two non-equivalent phosphorus atoms. A 2Jpp coupling could not be 
observed in water. This complex is not very active for hydrogenation. Because 
P-C bond cleavage on Rh-phosphine complexes is well known (2 6), we 
speculate that a similar oxidative addition of the phosphorus-naphthyl bond 
to the Ru center is occurring. P-C bond cleavage has been observed during the 
synthesis of Ru-BINAP complexes in organic solvents (27). Since the oxidative 
addition of a P-C bond from a phosphine to a transition metal center is 
promoted by the presence of a vacant coordination site, an aromatic co-solvent 
(a weakly coordinating agent) can be used to suppress the formation of the 
above mentioned "unsaturated species" that is proposed to be the responsible 
"intermediate" for the P-C bond cleavage (27). P-C bond cleavage has also 
occurred when combining BINAP-4S03Na with [Ru(cod)Cl2]n in water. A 
species with 19% abundance [31p NMR (D20): o = 76.0 and 85.0 ppm in 1:1 
ratio] is detected and is likely to be a complex with a coordinated 
1,5-cyclooctadiene. 
Treatment of [Ru(benzene)Cl2]2 (0.0037g) with two equivalents of 
water-soluble BINAP-4S03Na (0.0187g) in 4.5 ml of a 1:8 benzene/methanol 
solvent mixture at 55-60°C for one hour produces a clear, brownish-yellow 
colored solution. The 31p NMR spectrum of this solution in CD30D reveals 
two doublets at o = 63.0 and 68.8 ppm (J :::::: 45Hz). Identical results are obtained 
with [Ru(cod)Cl2]n as precursor. These data indicate that the same species is 
formed in these syntheses. Thus, the complex contains no 1,5-cyclooctadiene. 
The splitting is attributed to a loss in symmetry in the molecule; most likely 
due to a coordinated benzene molecule in [Ru(BINAP-4S03Na)(benzene)X]n+ 
34 
(X = Cl or solvent; n=1 or 2). When this species is dissolved in D20, only a 
singlet is found in the 31 P NMR spectrum regardless of the ruthenium 
precursor used [31p NMR (D20): o = 57.5 ppm]. Such degeneracy indicates 
that the two P-C bonds are still intact. Vacuum drying of this D20 solution 
yields a dark brown solid that when dissolved in CD30D regenerates the 
same 31p NMR spectrum as before [31p NMR (CD30D): o = 63.0 and 68.8 
ppm]. This reversible process indicates the species in D20 retains a 
coordinated benzene molecule. We therefore speculate that the complex is 
[Ru(BINAP-4S03Na)(benzene)]2+, obtained through the aquation of the Ru-
Cl bond. These two ruthenium complexes are found to be active asymmetric 
hydrogenation catalysts (vide infra). In addition, polymeric ruthenium 
complexes can also be the active catalytic components. 
Catalytic Studies 
The brownish yellow solid isolated from the 1:8 benzene/methanol 
solvent was used as a catalyst for olefin hydrogenation without further 
purification. Asymmetric hydrogenations of prochiral 2-acylamino acid 
precursors and methylenesuccinic acid (Figure 3.1) were conducted with a 
solution of 0.014-0.017M of substrate at either room temperature or 50°C and 
atmospheric to 100 atmospheres of hydrogen pressure in batch autoclaves. 
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Figure 3.1 Reaction scheme for the reduction of prochiral substrates 
[Rh) or [Ru)![L*)/[Hil 
1: R1 =H R2=H R3=Me X=N 
2: R1 =H R2=Me R3=Me X=N 
3: R1 =Ph R2=H R3 =Me X=N 
4: R1=H R2=H R3=H X=CH 
d OO,Na 
P (---y h 
OO,Na 
L * =BINAP-4S03N a 
In a typical run, a conversion of 80-100% was found in 48 hours. The 
conversion was measured by 1H NMR spectroscopy and the enantiomeric 
excess (e.e.) determined by gas chromatographic analysis using either a J. & 
W. Scientific CDX-B chiral capillary column or a Heliflex Chirasil-Val capillary 
column after derivatization of the reaction products (28). 
In all the reductions catalyzed by the water-soluble, ruthenium 
sulfonated-BINAP complex, the directions of enantioselection are found to be 
the same as those obtained from Ru-BINAP in organic solvent (from now on 
denoted as the parent system) (2 0 b). Representative examples of the 
asymmetric hydrogenation of prochiral olefins are shown in Table 3.1. 
Enantiomeric excesses as high as 85-88% have been achieved in both the 
hydrogenations of methyl-2-acetamidoacrylate and 2-acetamidocinnamic acid. 
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To our knowledge, this is the first example of a water-soluble, ruthenium-
based, chiral sulfonated diphosphine catalyst for asymmetric hydrogenation 
of prochiral alkenes. Similar to its parent system, the chirality induced in the 
products by this water-soluble ruthenium catalyst is opposite to that obtained 
from its water-soluble Rh-BINAP-4S03Na catalyst in a similar solvent system 
(20b, 25). In contrast to our previous findings with the water-soluble rhodium 
analogue, the enantioselectivity from the ruthenium-catalyzed hydrogenation 
of 2-acetamidoacrylic acids and methylenesuccinic acid shows an opposite 
trend in solvent dependence, the highest e .e . (up to 85%) is found in neat 
methanol (Tables 3.1 & 3.2). The drop in e.e. in neat water is recoverable by an 
increase in reaction temperature and an 82% e .e. in neat water is obtained at a 
reaction temperature of 50°C (vs. 85% e .e. in neat MeOH at 50°C). An increase 
in reaction temperature is not possible with the rhodium-based catalysts 
because of their lack of thermal stability in either organic or aqueous solvents. 
For the reduction of 2-acetamidocinnamic acid, the water-soluble ruthenium 
catalyst appears to give a slightly higher e .e . in neat water (87.7%) than when 
using methanolic solvents (81.3% Tables 3.1 & 3.2). 
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Table 3.1 Asymmetric hydrogenation of 2-acylamino acid precursors and methylene-
succinic acid by water-soluble ruthenium (II) sulfonated BINAP complex 
under one atm. of hydrogen. t 
Catalyst Substrate Solvent s;c:l: Temp.(0 C} e.e. (%) 
[Ru(BINAP-4S03Na)Cl2] 1 MeOH 71 RT 84.2(R) 
1 H20 18 RT 68.5(R) 
2 H20 80 RT 75.9(R) 
2 H20 76 50 82.0(R) 
2 MeOH 75 50 85.0(R) 
Ru2Cl4(BINAP)2(Et3N) 1 1:1 EtOH(THF - 35 76.oa 
[Ru(BINAP-4S03Na)Cl2] 3 MeOH 75 RT 81.3(R) 
3 EtOH 75 RT 80.1(R) 
3 H20 75 RT 87.7(R) 
Ru2Cl4(BINAP)2(Et3N) 3 1:1 EtOH(THF - 35 86.oa,b 
[Ru(BINAP-4S03Na)Cl2] 4 MeOH 75 RT 81.1 
4 MeOH 75 RT 9o.ob 
4 H20 18 RT 50.0 
Ru2Cl4(BINAP)2(Et3N) 4 1:1 EtOH(THF - 35 88.oa,b 
1: 2-acetamidoacrylic acid 2: e thyl-2-acetamidoacry late 
3: 2-acetamidocinnamic acid 4: methylenesuccinic acid 
t: substrate cone. = 0.014-0.017M :j:: S/C =substrate to catalyst ratio 
a: from ref. 20b and two atm. of hydrogen 
b: with the addition of triethylamine, Et3N/Substrate = 1 
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Table 3.2 Asymmetric hydrogenation of 2-acetarnidoacrylic acid and 2-acetam.ido-
cinnarnic acid by water-soluble ruthenium sulfonated BINAP catalyst in 
various water/methanol mixtures at room temperature and 1 atm. of Hz. 
Substrate Solvent s;c+ Concentration t (M) e.e. (%) 
1 H20 18 0.017 68.5 (R) 
1 7:3 H20 /MeOH 23 0.017 71.7 (R) 
1 3:7 H20 /MeOH 55 0.017 76.9 (R) 
1 MeOH 71 0.017 84.2 (R) 
3 MeOH 75 0.015 81.3 (R) 
3 1:1 MeOH/H20 75 0.015 84.0 (R) 
3 H20 75 0.017 87.7 (R) 
3 EtOHa 75 0.016 80.1 (R) 
1: 2-acetamidoacrylic acid 3: 2-acetamidocinna.mic acid 
:j:: S/C =substrate to catalyst ratio t: substrate concentration 
a: catalyst prepared from [Ru(p-cymene)Cl2l2 in neat ethanol 
The enantiomeric excess obtained in neat ethanol is almost the same as 
that from neat methanol. At this stage, it is impossible to explain the origin of 
the solvent dependent enantioselectivity. It is quite clear that the solvent effect 
is not only ligand-sensitive but also substrate dependent. For example, 
methylenesuccinic acid is hydrogenated with 81% e.e. in neat methanol as 
compared to only 50% e .e. in neat water. In spite of this, the 50% e.e. for this 
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substrate is already among the most enantioselective water-soluble systems 
ever reported in the literature (9). 
Reductions at higher pressure have also been examined and the results 
are summarized in Table 3.3. The data show that the enantioselectivity 
declines with increasing hydrogen pressure regardless of substrate. In 
particular, the hydrogenation of methylenesuccinic acid is the most pressure-
sensitive. These results are in agreement to those observed from the parent 
system where high hydrogen pressure and low reaction temperature lowered 
the enantiomeric excesses in the asymmetric hydrogenation of these types of 
substrates (27) . 
For the reduction of methylenesuccinic acid, the addition of 
triethylamine to the reaction system gave interesting results (Table 3.4). A 9% 
increase in e.e. is found in neat methanol with the addition of triethylamine 
(in 1:1 molar ratio between the base and the substrate). A maximum of 90% 
e.e. is obtained in neat methanol. However, an almost 16% drop in e.e. is 
observed in neat water when triethylamine is added. 
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Table 3.3 Pressu re effect on the enantioselection for the asymmetric hydrogenation of 
2-acylamino acid precursors and methylenesuccinic acid by water-soluble 
ruthenium (II) sulfonated BINAP catalyst at RT. 
Substrate Solvent Conc.t (M) s; c+ Pressure (atm) e.e. (%) 
3 MeOH 0.015 75 1 81.3(R) 
3 MeOH 0.012 75 50 64.0(R) 
3 1:1 MeOH/ H20 0.045 75 1 84.0(R) 
3 1:1 MeOH/ H20 0.045 75 50 6l.O(R) 
3 1:1 MeOH/ H20 0.012 75 55 64.0(R) 
3 H20 0.017 75 1 87.7(R) 
3 H20 0.017 76 5 82.5(R) 
3 H20 0.017 75 50 68.3(R) 
2 MeOH 0.015 75 1 84.7(R) 
2 MeOH 0.015 76 10 72.0(R) 
2 H20 0.017 75 1 75.9(R) 
2 H20 0.017 77 10 50.6(R) 
4 MeOH 0.015 75 1 81.1 
4 MeOH 0.017 75 50 18.2 
4 MeOH 0.017 75 100 10.1 
2: methyl-2-acetamidoacrylate 3 : 2-acetamidocinnamic acid 
4: methylenesuccinic acid t: substrate concentration 
:t:: S/C =substrate to catalyst ratio 
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Table 3.4 Effect of added triethylamine on the enantioselectivities for the asymmetric 
hydrogenation of methylenesuccinic acid and methyl-2-acetamidoacrylate by 
water-soluble ruthenium (II) sulfonated-BINAP catalyst at RT and one 
atmospheric pressure of hydrogen. 
Substrate Solvent Conc.t (M) s; c:t: Et3N/ Substrate (M/M) e .e. (%) 
4 MeOH 0.015 75 0 81.1 
4 MeOH 0.015 75 1 90.0 
4 H20 0.014 18 0 49.6 
4 H20 0.015 75 1 34.0 
4 EtOH(THF 0.050 50 0 B6.oa 
4 EtOH(THF 0.050 50 1.2 88.0b 
2 MeOH 0.017 85 0 84.7(R) 
2 MeOH 0.015 76 1 62.7(R) 
2: meth y 1-2 -acetamidoacry late 4: methylenesuccinic acid 
t : substrate concentration :t:: S/ C =substrate to catalyst ratio 
a: RuHCl(BINAPh [Et3N being added during the catalyst synthesis] as catalyst at 35°C 
and 2 atm. of hydrogen (ref. 20b) 
b: Ru2Cl4(BINAP)2(Et3N) as catalyst at 35°C and 2 atm. of hydrogen (ref. 20b) 
In the literature, there are no other studies on the effect of the addition 
of organic base on enantioselectivity for other water-soluble systems and it is 
therefore impossible for us to make any comparison. 
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Further experiments are currently being conducted on: (i) improved 
catalyst preparation, (ii) catalyst characterization, (iii) hydrogenations of other 
substrates with pharmaceutical applications, (iv) activity studies, (v) the 
effects of additions of inorganic bases and weakly coordinating co-solvents on 
enantioselectivity and (vi) catalysis in supported aqueous-phase configuration 
(29). Promising results from the SAPC system have been obtained and these 
data will be published later. 
CONCLUSION 
A one-step synthesis of a water-soluble, chiral ruthenium (II) 
sulfonated BINAP complex in methanolic solvent is accomplished. This is the 
first literature reported water-soluble ruthenium (II)-sulfonated chiral 
diphosphine complex. Similar to the synthesis of the non-sulfonated complex, 
a weakly coordinating co-solvent is required to inhibit the oxidative cleavage 
of P-C bonds when synthesizing the ruthenium complex with the water-
soluble diphosphine ligand. The performance of the water-soluble ruthenium 
complex as an asymmetric hydrogenation catalyst is found to be as 
enantioselective as its non-water-soluble analogue in alcoholic solvents. In 
some circumstances, the present system is superior to the non-sulfonated 
complexes, e.g., an 85.0% e .e. is obtained for the hydrogenation of 2-
acetamidoacrylic acid by the sulfonated ruthenium complex in methanol at 
RT, where only an 76% e .e. is obtained by Ru2Cl4(BINAP)2(Et3N) even at 
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35°C and 2 atrn of hydrogen pressure (20b) . Similarly, a 90.0% vs. 88.0% e .e. is 
found in the reduction of methylenesuccinic acid (20b) . However, when the 
hydrogenation is carried out in neat water, there is a drop in enantioselectivity 
for some of the substrates. Nevertheless, a 75.9% e.e. is found when this water-
soluble ruthenium catalyst is used to hydrogenate methyl-2-acetamidoacrylate 
in neat water and this value is comparable to the parent system that gives a 
76.0% e .e. even after the addition of triethylamine (20b) . Additionally, the 
hydrogenation of 2-acetamidocinnamic acid yields a slightly higher e.e. (87.7% 
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ABSTRACT 
A supported aqueous-phase, asymmetric, hydrogenation catalyst, SAP-
Ru-BINAP-4S03Na, is synthesized. Impregnation of water from an organic 
phase, ethyl acetate, is used to hydrate the SAP catalyst. Both the activity and 
enantioselectivity for the asymmetric hydrogenation of 2-(6'-methoxy-2'-
naphthyl)acrylic acid to naproxen are found to be dependent on the water 
content. Maximum activity and e.e. are observed when water saturated ethyl 
acetate is used to hydrate the SAP catalyst, an initial turnover frequency of 
18.2 hr-1 and an 70.0% e.e. at room temperature under -1350 psig of hydrogen 
pressure. At similar conditions, initial turnover frequencies of 131 hr-1 and 
0.34 hr-1 are observed from Ru-BINAP-4S03Na in homogeneous (methanol as 
solvent) and two-phase (water-ethyl acetate) reaction systems, respectively. 
Though an excellent 96.1% e .e. (at 4°C and 1230 psig of H2) is found in neat 
methanol (homogeneous), the enantioselectivity of the SAP catalyst (up to 70% 
e .e.) is bounded by the intrinsic enantioselectivity limit of the ruthenium 
complex in water. Recycling of the SAP catalyst is easily achieved without any 
leaching of ruthenium into the organic phase. 
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INTRODUCTION 
Homogeneous catalysts are known to exhibit high activities and 
selectivities at relatively mild reactions conditions giving few by-products (1). 
These characteristics are especially true in the synthesis of chiral compounds 
(2-4). Among the numerous types of chiral transformations, asymmetric, 
catalytic hydrogenation of prochiral alkenes is one of the most impressive 
achievements in catalytic selectivity (5). However, it has long been recognized 
that a shortcoming of homogeneous catalysis is the obvious need for 
separating the catalytic species from the reaction mixture. Depending upon 
the system: (i) the catalytic species can be very expensive (6,7), e.g., rhodium 
phosphine complexes, (ii) the catalytic species may not be robust enough for a 
particular separation and/ or the separation may not be as complete or cost 
effective as desired, and (iii) catalyst contamination in pharmaceutical 
products must be minimized. Therefore, there continues to be a need for the 
immobilization of the catalytically active organometallic species in order to 
enhance the economic viability of the reaction system by eliminating 
separation and/ or catalyst recovery steps and to minimize the possible 
toxicity hazards by contamination of trace transition metal complexes. 
Techniques used to immobilize homogeneous catalysts have centered on the 
retention of the structure and properties of the homogeneous counterpart. 
Comprehensive reviews on immobilization techniques are available (8-11) . 
Also, there are several informative reviews concerning numerous aspects of 
heterogeneous, enantioselective catalysis (12-22). 
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Hydrogenation is arguably the most important synthetic application of 
asymmetric catalysis because of its potential to produce a wide variety of 
chiral functional groups. It is therefore not surprising that the largest number 
of catalytic systems has been described for this reaction type. However, a 
closer inspection of the literature reveals that there are really only two families 
of synthetically useful heterogeneous, asymmetric catalytic systems: (i) aNi 
catalyst modified with tartrate/NaBr (12) and (ii) Pt(Pd) catalysts modified 
with cinchona alkaloids (23,24). Though many functionalized olefins can now 
be hydrogenated with optical yields> 95% using homogeneous catalysts (25), 
the performances of many heterogeneous systems are not that impressive. In 
fact, at this time there is no heterogeneous system for the enantioselective 
reduction of C=C bond that is preparatively useful. One way to create a 
heterogeneous catalyst is through the immobilization of a homogeneous 
catalyst onto a support. In this way, the catalyst can in principle acquire the 
property of insolubility and at the same time, retain the same reactivity and 
selectivity exhibited by its homogeneous analogue. In attempts to do these, 
homogeneous catalysts have been attached to a variety of supports including 
cross-linked polymers (9,26-30). Cross-linked polystyrenes are one of the most 
widely used polymer supports for the attachment of phosphine ligands 
through chemical modifications. In some cases, in highly polar solvents, 
enhanced rates (31,32) and greater selectivity for non polar olefins (vs. polar 
ones) (32,33) have been reported in hydrogenations mediated by polymer-
attached achiral phosphine systems. However, results with polystyrenes 
containing optically active phosphine ligands aimed at effecting asymmetric 
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syntheses have been disappointing (34). In polar solutions of the substrates, 
the polystyrene beads collapse preventing entry of the substrate to the 
catalytic site. Problems of polymer shrinking in polar solvents (34) and 
leaching of catalytic species from the support have always been the main 
obstacles. 
Recently, new generations of asymmetric hydrogenation catalysts have 
been synthesized and consist of Rh (1), Ru (II), Ni (II) or Co (II) complexes 
anchored in modified USY zeolites (35-37). These catalysts reveal a remarkable 
support effect on the enantioselectivity for the catalytic hydrogenation of 
prochiral alkenes. However, this system suffers from a constraint that limits its 
potential applications, i.e., the small pore size (-8A) only allows small 
substrate molecules to be reacted. Hence, a new type of support as well as the 
active catalytic species has to be found to achieve a practical heterogeneous, 
asymmetric hydrogenation catalyst for general use. 
The supported aqueous-phase catalysis (SAPC), developed by Arhancet 
et al. in 1989 (38), in combination with recent developments in the synthesis of 
water-soluble, chiral ruthenium sulfonated-BINAP complexes (39) allows the 
extension of the SAPC concept to chiral chemistry. We now describe an 
asymmetric version of supported aqueous-phase catalysis. The catalytic phase 
that is immiscible with the organic phase containing the reactants/products 
consists of an aqueous solution of a water-soluble ruthenium (II) sulfonated-
BINAP catalyst (see Figure 4.1) . Here, we report the preparation of this 
supported aqueous-phase, ruthenium, asymmetric hydrogenation catalyst and 
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its use in the asymmetric synthesis of naproxen. This immobilized ruthenium 
catalyst is shown to be an enantioselective hydrogenation catalyst. 




Controlled pore glass CPG-240 (CPG Inc.), benzeneruthenium (II) 
chloride dimer, ethyl acetate, pyridine, triethylamine, sodium hydroxide, 3-
pyridinesulfonic acid and tetrahydrofuran were purchased in their highest 
purity available and used as received. 2-(6'-Methoxy-2'-naphthyl)acrylic acid 
was obtained as a gift from the Monsanto Company. The sodium salt of tetra-
sulfonated BINAP was prepared as reported previously (40) . Sodium 3-
pyridinesulfonate was synthesized by neutralizing an aqueous solution of 3-
pyridinesulfonic acid with sodium hydroxide, followed by recrystallization in 
methanol. Unless stated otherwise, all manipulations were performed under 
argon or nitrogen. Deionized water, distilled over potassium permanganate 
was used in all operations requiring water. All solvents, including water, were 
degassed by four to five freeze-pump-thaw cycles. 
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Catalyst Preparation 
0.0050 g of [Ru(benzene)Cl2]2 were reacted with two equivalents of 
water-soluble BINAP-4S03Na in 4.5 ml of a 1:8 benzene/methanol solvent 
mixture at 55-60°C for one hour. The resulting clear, brownish-yellow colored 
solution of [Ru(BINAP-4S03Na)(benzene)Cl]Cl was then vacuum dried at 
room temperature. The crude solid was re-dissolved in 2.5 ml water and the 
solution blended with 0.8-1.0 g of degassed CPG-240 [a narrow pore-size 
distribution glass: mean pore diameter = 242 A, pore volume = 0.89 ml/ g, 
surface area= 79 m2/g, mesh size= 120/200] for two hours, followed by 
vacuum drying at 40-SOoC. The final product was a dry, free-flowing yellow 
powder that was stored under argon at room temperature. The water content 
of this "dried" catalyst was estimated by thermogravimetric analysis to be 1.9 
wt%, while the ruthenium contents were 1.2-2.5x1o-5 mol/ g. Since the 
ruthenium catalyst is not as hydrophilic as the Rh-TPPTS catalyst used in 
previous SAPC studies on hydroformylation (38,41-42), re-hydration of the 
solid catalyst by vapor-phase impregnation is not feasible in the present 
system. The dried catalyst was re-hydrated from an organic phase that had 
been previously premixed with a controlled amount of water. It was found 
that most of the water remains in the organic phase upon contact with the 
CPG. The maximum water loading was obtained by using a water-saturated 
organic phase. Catalysts used in the homogeneous and the two-phase systems 
were prepared as described in our previous paper (39) . 
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Reaction Conditions and Analytical Methods 
Asymmetric hydrogenations of 2-(6'-methoxy-2'-naphthyl)acrylic acid 
were conducted at various temperatures and hydrogen pressures in a 25 ml 
stainless steel Parr batch reactor. Special care was taken in order to avoid the 
presence of oxygen at all times. The conversion was measured by 1H NMR 
spectroscopy on a G.E. QE-300 spectrometer at 300MHz and the enantiomeric 
excess (e.e .) determined by HPLC using a 25cmx4.6mm i.d. Regis (S,S)-Whelk-
0 1 column without derivatization. Thermogravimetric analyses (TGA) were 
obtained in air on a Du-Pont 951 thermogravimetric analyzer. Ruthenium 
analyses were performed by Galbraith Laboratories Inc. (Knoxville, TN). 
RESULTS AND DISCUSSION 
Since naproxen and many other chiral 2-arylpropionic acids are high-
valued pharmaceutical products, there is great economic incentive for the 
development of a practical process for the efficient asymmetric hydrogenation 
of 2-arylacrylic acids. Previous studies have shown that high hydrogen 
pressure and low reaction temperature elevated the optical yields in the 
asymmetric hydrogenation of 2-arylacrylic acids (43). Hence, the asymmetric 
hydrogenation of 2-(6'-methoxy-2'-naphthyl)acrylic acid (substrate 1; a 
precursor to naproxen) was chosen to be our model reaction in this study. 
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Both the homogeneous and the two-phase reaction systems were examined in 
order to establish a basis for comparison with the SAPC results. 
Homogeneous Catalytic Studies 
In contrast to most other sulfonated phosphine systems ( 44,45), the 
ruthenium sulfonated-BINAP catalyst is quite soluble in neat methanol and 
methanol is known to give highest e .e . in many of the asymmetric reactions 
catalyzed by non-sulfonated complexes. In fact, the asymmetric 
hydrogenation of substrate 1 by the parent Ru-BINAP system ( the term 
parent system will be used here to denote the non-sulfonated analogue) was 
also carried out in neat methanol (43) . Homogeneous, asymmetric 
hydrogenations of substrate 1 were conducted in methanolic solvents to allow 
a direct comparison between the sulfonated and parent system. Table 4.1 
summarizes the results obtained from the homogeneous reductions of 
substrate 1 in methanolic solvents. Reductions were carried out under a 
hydrogen pressure of 500-1400 psig. It was observed that the 
enantioselectivity was not very pressure-sensitive in this pressure range (less 
than a 2% variation in e.e. over this range; entries 1 & 2). It is clear that the 
presence of water tends to lower the e.e.'s (entry 3). This may be attributed to 
the compositional change of the ruthenium catalyst in the presence of water. 
The chloro ligand dissociates in the presence of water through the aquation of 
the Ru-Cl bond. Our present results suggest that a coordinated chloro ligand 
in [Ru(BINAP-4S03Na)(benzene)Cl]Cl found only in neat methanol, assists in 
enhancing the e .e. The retention of the chloro ligand in neat methanol may 
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prov ide the necessary molecular configuration to facilitate a more 
enantioselective binding with the substrate. Our speculation is reinforced by a 
recent report that the cationic complex [(Cp)Ru(BINAP)](PF6) is completely 
non-selective in the asymmetric hydrogenation of methyl acetoacetate, while 
its neutral chloro complex [(Cp)Ru(BINAP)Cl] gives a 76% e.e. (46). 
The addition of triethylamine in neat methanol not only improves the 
e.e . to 91.5% at a reaction temperature of 23°C (entry 8) and 96.1% at 4°C 
(entry 15) but also enhances the activity by a factor of seven. Initial turnover 
frequencies of 927hr-1 and 131hr-1 are observed in the presence and absence 
of triethylamine, respectively (entries 7 & 8). As the substrate chelation to the 
metal center is unlikely to be the rate-determining step, the base-induced 
deprotonation of the substrate carboxylic group for facile metal chelation 
cannot be responsible for this rate enhancement. In addition, no such rate 
enhancement effect is found in the [Ru(BINAP)(02CR)2] catalyzed 
hydrogenation of a,p-unsaturated carboxylic acids with the addition of 
tetrabutylammonium hydroxide (47). However, a slow initial turnover 
frequency of 0.77hr-1 (entry 11) under acidic conditions is found with the 
addition of excessive amount of concentrated sulfuric acid. Consistent with 
this, addition of trifluoromethanesulfonic acid to the [Ru(BINAP)(02CR)2] 
system results in complete loss in activity ( 47). 
An opposite effect on enantioselectivity of added triethylamine is found 
in aqueous methanolic solvent. An almost 4% drop in e .e. (entry 4) is found in 
1:1 methanol/water solvent system although the same rate enhancement is 
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again observed with the addition of triethylamine. These results are in 
agreement with our previous findings of the solvent-dependent effects of 
added triethylamine on enantioselectivity with other substrates (39) . Other 
bases were also tested in these initial screening experiments. Water-soluble 
sodium 3-pyridinesulfonate is found to have little effects on enantioselectivity 
either in neat methanol or in aqueous methanolic solvents (entries 9 & 10). 
These findings lead us to further investigate the origin of the enantioselectivity 
enhancement through the addition of triethylamine. It is apparent that the 
chiral modification is a direct consequence of the ligand effect and probably 
involves the coordination of triethylamine to the ruthenium center (thus, 
allowing a fine tuning of the enantioselectivity through steric and electronic 
effects). Because of the presence of an electron withdrawing sulfonate group, 
sodium 3-pyridinesulfonate is not expected to coordinate with the metal, and 
no change in enantioselectivity is found . In contrast, un-substituted pyridine is 
known to be a good ligand for d6 ruthenium (II) complexes and it generally 
gives species that are even more stable than those formed from aliphatic 
amines, e.g., triethylamine. No conversion is observed with the addition of 
pyridine in 1:1 methanol/water solvent under 1350 psig of hydrogen pressure. 
In addition, the effects of added tetrahydrofuran were also examined. 
Tetrahydrofuran, being a moderately cr-donating ligand, gives an almost 
unchanged 77.6% e .e. in 1:1 methanol/water solvent system at 1350 psig of 
hydrogen pressure (entry 12). Further experiments are currently being 
conducted in search for an aqueous-counterpart of triethylamine for 
applications in two-phase and SAP systems. Nevertheless, in neat methanol, 
the present system (96.1% at 4°C and 1230 psig of H2 in entry 15) is as 
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enantioselective as its parent system (96.0% at 0°C and 500 psig of H2 in entry 
16) (43). 
Two-Phase Catalytic Studies 
We examined a simple two-phase reaction system (results listed in 
Table 4.2) for comparison with the homogeneous catalytic results (Table 4.1) as 
well as the SAP catalysis discussed below. Anhydrous ethyl acetate was 
chosen as the organic solvent. When substrate 1 was charged into the 
hydrogenation reactor along with an aqueous solution of the ruthenium 
catalyst (10 ml of 1:1 ethyl acetate/water and S/C=50), a 53.6% conversion 
was observed in 3.5 days with an initial turnover frequency of 0.34 hr-1 (entry 
1). The two-phase reaction is therefore at least 350 times slower than the 
homogeneous reaction system. Because of the limited solubility of this 
substrate in water, most of the reaction is taking place at the interface of 
aqueous-organic phase and the rate is therefore limited by the interfacial 
surface area between the catalyst containing aqueous phase and the substrate 
containing organic phase. As will be mentioned in the next section, the present 
two-phase system is at least 50 times less active than the SAP system where a 
much larger interfacial surface area is provided from the high surface area 
CPG support. Because of a limited solubility of the substrate in water, we 
cannot rule out the possibility that a small portion of the conversion is by 
reaction in the bulk aqueous phase. An 78.4% e .e. is obtained from the two-
phase reaction. Recycling of the catalyst containing aqueous phase after phase 
separation is possible without any loss in enantioselectivity (entries 2, 3 & 4), 
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the e.e.'s range from 78.0-82.7% over several recycles of the catalytic solution. 
Similar e.e.'s but lower activities (0.20 hr-1) were found at a reaction 
temperature of 5-6°C (entry 5). Addition of triethylamine increased the 
reaction rate at a slight expense of enantioselectivity (entry 6). Similar results 
on the effects of added triethylamine have been reported in our previous work 
on other substrates (39). 
Supported Aqueous-Phase Catalytic Studies 
In the supported aqueous-phase configuration, anhydrous ethyl acetate 
is used as the organic phase and the catalytic data obtained from this system 
are listed in Tables 4.3 and 4.4. The activities of the SAP catalysts are improved 
over the two-phase system due to the much higher interfacial area of SAP 
catalyst. When substrate 1 (S/C=25) is hydrogenated with a "dried" sample of 
the SAP catalyst (1.9 wt% water), no detectable conversion is observed even 
after 70 hours at room temperature under 1300psig of hydrogen pressure 
(T.O.F. < 0.008 hr-1, entry 1 in Table 4.4). Significantly, when water-saturated 
ethyl acetate is used as solvent, a 100% conversion (S/C=31.5) is achieved in 
-3 hours under the same reaction conditions with an initial turnover 
frequency of 18.2 hr-1 and an 70% e.e. (entry 5 in Table 4.3 and entry 8 in Table 
4.4). This enantioselectivity is only slightly lower than that found in the water-
organic two-phase system. Similar results are also observed from other 
batches of SAP catalysts (entries 2, 6 & 9 in Table 4.3). Additionally, when 
using a SAP catalyst with 40Jll water in 10ml of ethyl acetate as the organic 
solvent, the e .e. of the hydrogenated product is found to be only 28.7% (R) 
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(entry 1 in Table 4.3). It is therefore evident that the water content in the SAP 
catalyst has dramatic effects both on the activity and the enantioselectivity. 
Since the present ruthenium-sulfonated-BINAP catalyst is not as hydrophilic 
as the rhodium-TPPTS catalyst, developed by Arhancet et al., vapor-phase 
impregnation of water onto the CPG support is not feasible for the present 
system (38,41). The revised method of in-situ rehydration by water-loaded 
blank CPG also requires higher reaction temperatures (80-100°C) for the 
redistribution of water over the SAP catalyst (42). Again, this approach for 
loading water in the present SAP catalyst is not possible. However, another 
rehydration procedure that is more feasible, especially in terms of scale-up, 
was devised for this particular system; namely, the organic-phase 
impregnation. The "dried" SAP catalyst is rehydrated from an organic-phase 
that has been previously premixed with a controlled amount of water. In 
order to achieve a reasonable activity, the amount of water added to the 
organic phase is found to be greater than the void volume of the CPG support 
(60-70 !J-l) suggesting a large portion of water is still retained in the organic 
phase. A maximum water loading of 2.8-3.1 wt% (g H20/g AcOEt x 100, i.e., 
-275 j..Ll water in 10 ml of ethyl acetate) was accomplished by using a water-
saturated organic phase. The initial turnover frequencies as a function of 
water content are listed in Table 4.4 (reaction conditions: 
substrate/ruthenium-30, [substrate]=4.6-4.8x1o-3M, pressure=1350-1400psig, 
T=25°C, stirring speed=350rpm). Water is introduced to the "dried" SAP 
catalyst from the ethyl acetate (10 ml) and the content controlled by adding 
variable amounts of water, e.g., 0, 40, 125, 145, 160, 195, 215 and 270 !J-l. The 
maximum activity, as determined by the initial turnover frequency, is 
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observed at the highest water content ( -3 wt% water in ethyl acetate) with an 
initial turnover frequency of 18.2 hr-1 (entry 8 in Table 4.4). The 
enantioselectivity of the SAP catalyst is also dependent on the water content 
and shows a similar trend to that observed in the activity; the observed range 
is 28.7% to 70.0%(R) (entries 1 & 5 in Table 4.3) . Thus, as previously 
mentioned, the water content affects the activity and enantioselectivity of the 
SAP catalyst. The present findings are quite different from what have been 
observed in the hydroformylation of 1-octene by a SAP-rhodium-TPPTS 
catalyst (41). In the hydroformylation of 1-octene, the activity is much more 
sensitive to the water content of the SAP catalyst with a bell-shaped curve that 
describes the activity dependence on water content. Maximum activity is 
observed at -8 wt% (g H20/g SAPC x 100) water content of the SAP catalyst 
and complete loss of activity is observed at -50 wt% (41). Two factors appear 
to be responsible for the difference in behaviour towards the water content of 
these two SAP catalysts. First, the [Ru(benzene)(BINAP-4S03Na)]2+ complex 
is stable even in neat water while HRh(CO)(TPPTS)3 is not at high synthesis 
gas pressure. At high water loading, the HRh(CO)(TPPTS)3 complex 
decomposes, resulting in a drop in activity. Second, the decrease in the 
interfacial area of the SAP catalyst with increasing water loading also 
contributes to the rapid decline in the activity of the more hydrophilic SAP-
Rh-TPPTS catalyst. Because of the small partition coefficient of water between 
the CPG support and the ethyl acetate, conditions have not yet been reached 
in the present SAP-Ru-BINAP-4S03Na that approximates the high water 
loading obtained with the SAP-TPPTS catalyst. Thus, the actual amount of 
water being loaded onto the SAP-Ru-BINAP-4S03Na catalyst is far below the 
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amount loaded by the vapor-phase impregnation into the much more 
hydrophilic SAP-Rh-TPPTS catalyst. 
In view of the high water content of the ethyl acetate in the present 
system, the leaching of the catalytic species into the organic phase may be 
more likely than with anhydrous solvents. Filtration of the reaction mixture to 
remove the solid catalyst after the hydrogenation reaction yields a colorless 
solution of product in ethyl acetate. All filtrates were found not to contain any 
ruthenium at a detection limit of 1 ppm (entries 2, 4-5 & 15 in Table 4.3 and 
entries 3-8 in Table 4.4). In addition, for some of the experiments, filtrates were 
tested indirectly for the presence of ruthenium by attempting the catalytic 
hydrogenation of methylenesuccinic acid using the filtrate alone as catalyst. In 
no case was catalytic activity observed from the filtered solutions. For 
example, filtered solutions gave no conversion of methylenesuccinic acid at 
room temperature with one day of contact under a pressure of 30 psig of 
hydrogen. The inactivity of these filtered solutions together with the elemental 
analyses suggests that no soluble ruthenium species have leached out into the 
organic phase. 
It is reasonable to suggest that the ruthenium complex becomes 
increasingly mobile (does not necessarily imply translational mobility but 
rather rotational mobility) as the water loading increases, as evidenced from 
the data in Table 4.4 that the hydrated SAP catalyst is at least 2000 times more 
active than the "dried" SAP catalyst. With a higher degree of mobility, the SAP 
catalyst can approach the same enantioselectivity as its counterpart in the two-
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phase system. (Increased mobility with higher water contents was shown 
previously to occur with the SAP-Rh-TPPTS catalyst (41)). Because of the 
much larger interfacial surface area between the catalyst containing aqueous-
phase and the substrate containing organic-phase, the SAP system is found to 
be at least 50 times more active than the two-phase system. In the best cases, 
T.O.F.'s obtained using hydrated SAP catalysts are only a factor of 7 times 
slower than homogeneous catalyst in neat methanol under the same 
conditions. We have observed a similar drop (6.7 times) in initial turnover 
frequency in the homogeneous hydrogenation of methyl-2-acetamidoacrylate 
by [Rh(BINAP-4S03Na)(H20)]+ in neat water (40), where both the substrate 
and the catalyst are mixed together in one single phase and attributed this to 
the fact that hydrogen solubility is four to five times higher in alcoholic 
solvents (oxidative addition of hydrogen to the rhodium catalyst is rate 
determining). 
The effect of added base on the SAP system was examined and the 
results are listed in Table 4.3. The addition of either aqueous sodium 
hydroxide or triethylamine is found to have little effect on the 
enantioselectivity (entries 13, 15-16 in Table 4.3). In the presence of sodium 
hydroxide, the enantioselectivity is found to be rather pressure-insensitive in 
the pressure range of 500-1,400 psig (entries 17-19 in Table 4.3). The e.e.'s are 
almost constant from the hydrated SAP catalyst in the pressure range of 500-
1,400 psig (entries 2 & 3 in Table 4.3). Similar to the case of the homogeneous 
analogue, higher e .e.'s (77%) are achieved with a lower reaction temperature 
of 8°C, but at the expense of activity (T.O.F.=0.43hr-1). The possibility of 
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catalyst decomposition during the synthesis of SAP material is ruled out by 
the fact that a hydrogenation of substrate 1 with an 86% e.e. is accomplished 
by using a redissolved catalyst solution from a used SAP catalyst in methanol. 
Thus, the ruthenium complex is still stable in the SAP configuration. It is 
therefore apparent that the performance of the hydrated SAP catalyst is 
bounded by the intrinsic enantioselectivity limit of the ruthenium sulfonated 
BINAP catalyst in water. Additionally, it is clear that the CPG support plays 
no important role in the enantioselection. 
Series of reactions were carried out to test the possibility of recycling 
the SAP catalyst. The used SAP catalyst was removed from the hydrogenation 
mixture by simple filtration. It was then washed several times with fresh ethyl 
acetate, followed by the addition of fresh substrate and solvent. Similar values 
of e.e. (65-70%) were found throughout the recycling of the SAP catalyst 
(entries 2, 4-5, 6-8 & 9-11 in Table 4.3). 
CONCLUSION 
A supported aqueous-phase, asymmetric, hydrogenation catalyst, SAP-
Ru-BINAP-4S03Na, is prepared. Because of the much larger interfacial area 
due to the CPG support, the SAP catalyst is found to be at least 50 times more 
active than its two-phase counterpart and only 7 times less active than its 
homogeneous analogue. Both the catalytic activity and enantioselectivity are 
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dependent on the water content of the SAP catalyst, with the hydrated SAP 
catalyst being at least 2,000 times more active than the dried catalyst. It is 
suggested that the mobility of the ruthenium sulfonated-BINAP complex on 
the surface of the CPG support is very critical to the overall performance of 
this SAP catalyst. Although the active ruthenium sulfonated BINAP catalyst 
(96.1% e.e.) is as enantioselective as its non-sulfonated analogue (96.0% e .e.) 
under homogeneous conditions, the performance of its SAP version is only 
moderate and bounded by the intrinsic enantioselectivity limit of the 
ruthenium catalyst in water. The loss of the chloro ligand through aquation of 
the Ru-Cl bond in water is proposed to be responsible for the decline in 
enantioselectivity. From this work, the concept of supported aqueous-phase 
catalysis has been demonstrated to be applicable to asymmetric catalysis. The 
advantage of easy catalyst separation and recycling makes this system 
attractive in the transition-metal-catalyzed asymmetric synthesis of high-
valued specialty chemicals, though further refinements on detailed 
configurations have to be developed before a genuine practical heterogeneous 
chiral catalyst can be achieved for general use. 
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Homogeneous, asymmetric hydrogenation of 2-(6'-methoxy-2'-naphthyl)acrylic acid by 
[Ru(BINAP-4S03Na)(benzene)]2+ complex in methanolic solvents at room temperature. 
Entry Solvent SIca Hydrogen 
Pressure (psig) 
1 MeOH 50 1370 86.0 (R) 
2 MeOH 53 500 84.7 (R) 
3 1:1 MeOHIH20 25 1320 78.9 (R) 
4 1:1 MeOHIH20 25 1340 75.1 (R)d 
5 MeOH 25 1370 89.5 (R)d 
6 MeOH 25 1360 91.0 (R)d 
7 MeOH 101 1350 131 88.2 (R) 
8 MeOH 101 1350 927 91.5 (R)d 
9 MeOH 51 1370 86.2 (R)e 
10 1:1 MeOHIH20 51 1320 75.7 (R)e 
11 1:1 MeOHIH20 50 1350 0.77! 
12 1:1 MeOHIH20 52 1350 77.6 (R~ 
13 MeOH 52 500 87.5 (R)d 
14 MeOH 500 93.3 (S)d,h 
15 MeOH 100 1230 96.1 (R)d,i 
16 MeOH 500 96.0 (S)d,h,j 
a substrate to ruthenium ratio 
b initial turnover frequency 
c e.e. determined at 100% conversion 
d with added triethylamine, Et3N I substrate = 1 
e with added sodium 3-pyridinesulfonate, m-S03Na-pyridinelsubstrate = 1 
f with added concentrated sulfuric acid in 10 times excess of substrate 
g with added tetrahydrofuran in 1.9 times excess of substrate 
h ref. 43 
reaction temperature = 4 o C 
j . 0 reaction temperature = 0 C 
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TABLE4.2 
Two-phase, asymmetric hydrogenation of 2-(6'-methoxy-2'-naphthyl)acrylic acid by [Ru 
(BINAP-4S03Na)(benzene)]2+ complex in 1:1 ethyl acetate/water solvent mixture at room 
temperature. 
Entry S/Ca Hydrogen Stirring Reaction Conv. T.O.F. (hr-1)b e.e. (%) 
Pressure (psig) Speed (rpm) Time (D) (%) 
1 50 1380 250 3.5 53.6 0.34 78.4 
2 25 1360 250 1.5 56.7 81.1 
3 25 1360 250 1.5 56.4 78.QC 
4 25 1370 250 1.5 57.0 82.7d 
5 15 1365 450 2.8 90.0 0.20 77.2e 
6 14 1320 400 2.5 100.0 73.of 
a substrate to ruthenium ratio 
b initial turnover frequency 
c aqueous solution recycled once 
d aqueous solution recycled twice 
e . 0 reachon temperature = 5 C 
f with added triethylamine, Et3N/substrate = 1 
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TABLE 4.3 
Heterogeneous, asymmetric hydrogenation of 2-(6'-methoxy-2'-naphthyl)acrylic acid by SAP-
Ru-BINAP-4S03Na catalyst in ethyl acetate. 
Entry Cyclea Solvent s;cb Hydrogen Stirring e.e. (%) 
Pressure (psig) Speed (rpm) 
1 0 AcOEt (401-!l H20) 25 1300 350 28.7 (R) 
2 0 AcOEt (H20 sat.) 33 1300 350 69.0 (R)c 
3 1 AcOEt (H20 sat.) 30 500 350 68.3 (R) 
4 1 AcOEt (H20 sat.) 25 1330 350 68.6 (R)C 
5 2 AcOEt (H20 sat.) 25 1330 350 70.0 (R)c 
6 0 AcOEt (H20 sat.) 30 1360 300 67.0 (R) 
7 1 AcOEt (H20 sat.) 30 1360 300 67.0 (R) 
8 2 AcOEt (H20 sat.) 31 1360 300 66.0 (R) 
9 0 AcOEt (H20 sat.) 30 1330 500 69.0 (R) 
10 1 AcOEt (H20 sat.) 30 1250 500 65.0 (R) 
11 2 AcOEt (H20 sat.) 30 1050 550 66.0 (R) 
12 3 AcOEt (H20 sat.) 30 1260 350 77.0 (R)d 
13 5 AcOEt (H20 sat.) 31 1360 350 62.8 (R)e 
14 6 AcOEt (H20 sat.) 30 1350 350 63.6 (R) 
15 7 AcOEt (H20 sat.) 30 1370 350 64.6 (R)c,e 
16 0 AcOEt (200~-LlNaOH) 30 1380 350 62.8 (R)i 
17 1 AcOEt (NaOH sat.) 30 1380 350 59.9 (R)i 
18 2 AcOEt (NaOH sat.) 30 1000 350 59.8 (R)i 
19 3 AcOEt (NaOH sat.) 30 500 350 58.6 (R)i 
20 4 AcOEt (H20 sat.) 30 1350 350 62.7 (R) 
a number of catalyst recycles 
b substrate to ruthenium ratio 
c no ruthenium found in the filtrate with a detection limit of 1 ppm 
d reaction temperature= 8°C 
e with added triethylamine, Et3N I substrate = 1 
f with 0.22 M sodium hydroxide solution 
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TABLE 4.4 
Catalytic activity as a function of water content in the heterogeneous, asymmetric 
hydrogenation of 2-(6'-methoxy-2'-naphthyl)acrylic acid by SAP-Ru-BINAP-4S03Na catalyst 
in ethyl acetate. 










33 1330 0 <0.008 
25 1330 40 0.22 
30 1350 125 o.25d 
30 1360 145 l.06d 
31 1370 160 2.35d 
30 1400 195 2.84d 
30 1370 215 5.l2d 
32 1370 270 (saturated) 18.21 d 
a substrate to ruthenium ratio 
b hydrogenations were carried out in 10 ml of ethyl acetate at room temperature 
and with 350 rpm stirring speed , [substrate]=4.6-4.8x1o-3M 
c initial turnover frequency 
d no ruthenium found in the filtrate with a detection limit of 1 ppm. 
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CHAPTER FIVE 
Asymmetric Synthesis of Naproxen 
by 
A New Heterogeneous Catalysis 
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ABSTRACT 
A new heterogeneous, asymmetric catalyst is described. The catalyst 
is a modified version of the supported aqueous-phase catalyst reported 
previously (1), ethylene glycol is used in place of water as the hydrophilic 
phase. Both the enantioselectivity and the activity of this new 
heterogeneous catalyst are comparable to the homogeneous analogue in 
neat methanol (or ethylene glycol); e.e.'s: 95.7% vs. 96.1% and t.o.f.'s: 40.7 
hr-1 vs. 131.0 hr-1, respectively. Recycling of the catalyst is possible without 
leaching of ruthenium at a detection limit of 32 ppb. 
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INTRODUCTION 
Recently, we reported on the development of an asymmetric 
version of supported aqueous phase catalysis (SAPC) (1) . SAP catalysis 
enables the efficient use of a water-soluble organometallic complex to 
promote the reaction of substrates soluble in organic solvents (2) . In our 
previously reported SAP system (1), the water-soluble ruthenium complex, 
[Ru(BINAP-4S03Na)(benzene)Cl]Cl (BINAP=2,2'-bis(diphenylphosphino)-
l,l'-binaphthyl ), was impregnated onto a CPG support by the incipient 
wetness technique and the bulk water vacuum evaporated away. Both the 
activity and the enantioselectivity of the SAP catalyst were found to be 
sensitive to the amount of water on the catalyst. An in-situ organic-phase 
impregnation of water onto the "dried" SAP catalyst was developed to 
activate the catalyst. We speculated that the increase in mobility of the 
ruthenium complex on the support with increasing water loading led to 
increases in both the activity and the enantioselectivity of the hydrated 
SAP catalyst. It was shown also that the enantioselectivity limit of the 
hydrated SAP catalyst could approach that of its two-phase ( ethyl acetate -
water ) analogue. This indicates that the ruthenium complex on the CPG 
support is more or less as mobile as in homogeneous medium. This is an 
important point in the immobilization of homogeneous catalysts onto 
solid supports. Usually, the homogeneous catalysts are covalently bonded 
to the support and reveal limited mobility (3). This normally leads to an 
undesirable loss in activity and/ or selectivity. In the SAP system, it is the 
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aqueous catalyst solution that is immobilized on the support, not the 
individual organometallic complexes. This unique feature of the SAP 
catalyst may allow for the development of the first genuine hybrid of an 
active/selective homogeneous catalyst with all the features of a 
heterogeneous catalyst. 
The organometallic ruthenium catalyst used in the asymmetric SAP 
catalyst was found to exhibit a solvent dependent enantioselectivity when 
operated homogeneously (1,4). Although the homogeneous 
organometallic ruthenium catalyst was effective in promoting the 
asymmetric hydrogenation of 2-(6'-methoxy-2'-naphthyl)acrylic acid with 
96% e .e. in neat methanol, its enantioselectivity dropped to about 80% e .e. 
in water (1). As a result, the enantioselectivity of the hydrated SAP catalyst 
(up to 77% e .e.) was bounded by the intrinsic enantioselectivity limit of the 
organometallic ruthenium complex in neat water. Hence, further 
refinements on the SAP catalyst have to be made before a practical, 
heterogeneous, chiral catalyst can be developed for general use. 
We now report a new heterogeneous catalyst and its use in the 
asymmetric hydrogenation of 2-(6' -methoxy-2' -naphthyl)acrylic acid to 
naproxen. Here, we describe the new catalyst composition, a new method 





Controlled pore glass CPG-240 (a narrow pore-size distribution glass: 
mean pore diameter = 242A, pore volume = 0.89ml/ g, surface area = 
79m2/g, mesh size= 120/200), benzeneruthenium (II) chloride dimer, ethyl 
acetate, cyclohexane, chloroform, ethylene glycol and triethylamine were 
purchased in their highest purity available and used as received. 2-(6'-
Methoxy-2'-naphthyl)acrylic acid was received as a gift from Monsanto 
Company. The sodium salt of tetra-sulfonated BINAP was prepared as 
reported previously (5). Unless stated otherwise, all manipulations were 
performed under argon or nitrogen. Deionized water, distilled over 
potassium permanganate was used in all operations requiring water. All 
solvents, including water, were degassed by four to five freeze-pump-thaw 
cycles. 
Catalyst preparation and activation procedure 
The active organometallic ruthenium catalyst, [Ru(BINAP-
4S03Na)(benzene)Cl]Cl, was prepared and impregnated onto the CPG 
support by the previously described procedures (1) . The water content of 
this "dried" catalyst was estimated by thermogravimetric analysis to be 1.9 
wt%, while the ruthenium contents were 1.2-2.5xlo-5 mol/ g . Anhydrous 
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ethylene glycol was used to activate the "dried" catalyst. The impregnation 
was performed by two different techniques: (A) by the in-situ activation 
with ethylene glycol in ethyl acetate (ethylene glycol partitions between the 
organic solvent and the surface of the CPG), and (B) as follows. The "dried" 
catalyst was stirred in ethyl acetate that had been previously premixed with 
a controlled amount of ethylene glycol. The highly polar ethylene glycol 
was allowed to partition between the ethyl acetate phase and the CPG 
surface for about an hour. Because of a small partition coefficient for 
ethylene glycol between the CPG support and the ethyl acetate, it was 
found that most of the ethylene glycol remained in the organic phase upon 
contact with the "dried" catalyst. This procedure was then repeated. The 
bulk organic phase was then removed by filtration and the resulting 
catalyst was washed several times with a 1:1 chloroform and cyclohexane 
mixture that had been pre-mixed with ethylene glycol. 
Reaction conditions and analytical methods 
Asymmetric hydrogenations of 2-(6'-methoxy-2'-naphthyl)acrylic 
acid were conducted at various temperatures in a 25 ml stainless steel Parr 
batch reactor. Special care was taken in order to avoid the presence of 
oxygen at all times. Catalysts with various amount of ethylene glycol 
loading were used. Both the neat ethyl acetate and the 1:1 mixture of 
chloroform/ cyclohexane were used as the bulk organic phase (Sml). The 
conversion was measured by 1 H NMR spectroscopy on a G.E. QE-300 
spectrometer at 300 MHz and the enantiomeric excess (e.e.) determined by 
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HPLC using a 25cm x 4.6cm i.d. Regis (S,S)-Whelk-0 1 column without 
derivatization. Thermogravimetric analyses (TGA) were obtained in air on 
a Du-Pont 951 thermogravimetric analyzer. Ruthenium analyses of the 
reaction filtrates were performed by Galbraith Laboratories Inc. (Knoxville, 
TN). 
RESULTS AND DISCUSSION 
With a multi-million-dollar-a-year market, naproxen is currently 
the object of intense study by generic drug manufacturers (6). Hence, the 
asymmetric hydrogenation of 2-(6'-methoxy-2'-naphthyl)acrylic acid 
(substrate 1; a precursor to naproxen) was again chosen to be our model 
reaction in this study (Figure 5.1) . The results from this new 
heterogeneous catalyst are compared to those from the original hydrated 
SAP catalyst as well as the homogeneous and two-phase analogues (1). 
In our early study, we have shown that the presence of water tends 
to lower the enantioselectivity in the homogeneous hydrogenation of 
substrate 1 in methanolic solvents (1). Aquation of the ruthenium-chloro 
bond in water was found to be responsible for this solvent dependent 
enantioselectivity. To prevent the cleavage of the ruthenium-chloro bond, 
anhydrous ethylene glycol is used here in place of water. The 31p NMR 
spectrum of the ruthenium complex in 1:1 CD30D/ethylene glycol reveals 
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the same two doublets ( ~ = 63.0 and 68.8 ppm; J ::::: 45 Hz ) as is found in 
neat methanol indicating that the ruthenium-chloro bond in [Ru(BINAP-
4S03Na)(benzene)Cl]Cl is still intact. Upon addition of water, only a singlet 
( ~ = 57.5 ppm) is observed in the 31p NMR spectrum. These data suggest 
that a rapid hydrolysis of the ruthenium-chloro bond has occurred in the 
presence of water. As a result, hydrogenations of substrate 1 are carried out 
in the presence of ethylene glycol. Similar enantioselectivities (88-89% 
e.e.'s as shown in Table 5.1) are observed for reactions carried out in neat 
methanol, 1:1 methanol/ ethylene glycol and also in neat ethylene glycol. 
These findings further support the premise that the cleavage of the 
ruthenium-chloro bond has a detrimental effect on enantioselectivity. 
Only a 79% e .e. was observed in a 1:1 MeOH/H20 solvent mixture (Table 
5.1) (1) . Since the highly polar ethylene glycol is not miscible with most 
organic solvents, it can be used as a substitute for the aqueous phase in the 
original SAP system; it replaces the role of water in the immobilization of 
the ruthenium catalyst onto the CPG support. 
This new heterogeneous catalyst now consists of a ruthenium 
organometallic complex dissolved in a film of ethylene glycol which is 
supported on a high-surface-area hydrophilic CPG support (Figure 5.2). 
Similar to our previous findings with the hydrated SAP catalyst, both the 
activity and the enantioselectivity of the new catalyst are sensitive to the 
amount of ethylene glycol in the system. By using the in-situ organic-
phase impregnation of ethylene glycol, controlled amounts of ethylene 
glycol are introduced into the ethyl acetate and used as the bulk organic 
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phase. Replacement of neat water with ethylene glycol results in at least a 3 
times enhancement in the activity. An initial turnover frequency of 54.2 
hr-1 is observed at an ethylene glycol loading of 400 1-11 in 5 ml of ethyl 
acetate (Table 5.2), whereas only an 18.2 hr-1 of initial turnover frequency 
was observed from the original hydrated SAP catalyst (1 ). More 
importantly, this activity is only 2-2.5 times slower than the homogeneous 
analogue in either neat methanol or neat ethylene glycol (Table 5.2). We 
speculate the higher intrinsic activity of the ruthenium organometallic 
catalyst in neat ethylene glycol be responsible for the high activity of the 
new catalyst. This is further evidenced by the finding of a reasonably high 
rate in the two-phase system (15.3 hr-1 ). An almost 50-fold increase in 
activity is observed when ethylene glycol is used in place of water in 
the two-phase system ( 15.3 hr-1 vs. 0.34 hr-1 ). 
With the in-situ activation (method A) using ethylene glycol, 
enantioselectivities are found to increase with increasing amount of 
ethylene glycol in the system. The enantioselectivities as a function of 
ethylene glycol content are listed in Table 5 .3 (reaction conditions: 
substrate/ruthenium = 30, [substrate] = 3.6 x 103M, solvent volume = 5 
ml, pressure = 1400 psig, T = 24°C, stirring speed = 350 rpm). At a 
maximum ethylene glycol loading of 400 1-11 ( in 5 ml of ethyl acetate ), an 
87.7% e .e. is observed while only 45.0% e.e. is found for the system with 75 
1-11 of ethylene glycol. This is in agreement with our previous findings for 
the hydrated SAP systems where the higher the water content the higher 
the en an tioselecti vity ( 1) . More importantly, the new heterogeneous 
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catalyst with ethylene glycol as substitute for the aqueous phase has already 
achieved the same high enantioselectivity as its homogeneous analogue in 
neat methanol ( 87.7% vs . 88.2% ). By lowering the reaction temperature to 
3°C, the e.e. is increased to 94.8%. However, unlike the homogeneous 
analogue in neat methanol (1 ), addition of triethylamine to the 
heterogeneous catalyst is found to have a detrimental effect on 
enantioselectivity. An almost 15% drop in e.e. is observed at room 
temperature upon addition of triethylamine. This is rather unexpected 
since we believe that the active ruthenium catalyst is nearly the same as 
the one in neat methanol. Solvation of the ruthenium complex with 
ethylene glycol may be responsible for the decline in enantioselectivity 
upon addition of base, but the detailed mechanism is still unclear. Similar 
drop in e.e. is also reported in our original hydrated SAP system (1). 
For long-term stability, the heterogeneous catalyst must remain 
assembled. To test for this type of stability, a self-assembly test is performed 
in the following way: 1.1x1o-6 moles of [Ru(BINAP-4S03Na)(benzene)Cl]Cl 
is dissolved in 400 111 of ethylene glycol and loaded into a 25 ml Parr 
reactor. 5.7x1o-5 moles of substrate 1 in 5 ml of ethyl acetate is then added. 
Finally 0.1 g CPG-240 is added. The reactor is pressurized to 1,400 psig with 
hydrogen and stirred at 350 rpm and at room temperature. The reaction is 
stopped after one hour and analyzed. A control experiment is carried out 
in using exactly the same procedure with the exception that no CPG is 
added. Complete conversion of 1 is observed when CPG is added, while no 
detectable conversion is found in the control experiment. After the 
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reaction, the CPG support turns pale yellow and the bulk organic phase is 
colorless. These results indicate that, under the reaction conditions, the 
individual components of the heterogeneous catalyst self-assemble into a 
more thermodynamically stable supported-catalyst configuration. 
Therefore, the reverse, i.e., the separation of the solution and complex 
from the support, is unlikely to happen under reaction conditions because 
it is thermodynamically unfavorable. These results also support the 
inference that the reaction chemistry is taking place at the liquid-liquid 
interface. In the control experiment, most of the added ethylene glycol 
dissolved into the bulk organic phase and left behind small droplets of 
catalyst solution. The limited interfacial area of the catalyst solution that 
remains immiscible with the bulk organic phase results in the lack of 
activity in the control experiment. 
Unlike the original hydrated SAP catalyst, traces of ruthenium are 
found in the reaction filtrates. The extent of ruthenium leaching was 
found to be correlated with the ethylene glycol content in the organic 
phase as evidenced by the data shown in Table 5.4. Since ethylene glycol is 
less polar than water, it is at least 3 times more soluble than water in ethyl 
acetate. The higher solubility of ethylene glycol in ethyl acetate may be 
responsible for the observed leaching of ruthenium into the bulk organic 
phase. In order to minimize the leaching of ruthenium into the bulk 
organic phase, a new method of activation of the "dried" catalyst with 
ethylene glycol was devised, and is described below. 
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The "dried" catalyst was activated by stirring it in an ethylene 
glycol/ ethyl acetate solvent mixture. After equilibration for an hour at 
room temperature, the solid catalyst was filtered and dried at low vacuum 
( 0.2 atm. ). The procedure was then repeated. Only a thin film of non-
volatile ethylene glycol was deposited onto the solid catalyst. The amount 
of ethylene glycol in the film is more or less the same as that found with 
the original in-situ activation procedure, and a similar degree of mobility 
of the ruthenium complex on the support is to be expected. However, now 
an ethylene glycol-saturated organic phase is used so as to maintain the 
integrity of this film during the reaction. To minimize the amount of 
ethylene glycol used in the bulk organic phase, a rather non-polar 1:1 
solvent mixture of cyclohexane and chloroform ( for solubilization of 
substrate ) is used. As shown in Table 5.5, the same high enantioselectivity 
(88.4% e .e . at room temperature) is still obtained with this kind of 
activation procedure and more importantly, no ruthenium is found in the 
reaction filtrate at a detection limit of 32 ppb! By lowering the reaction 
temperature to 3°C, an 95.7% e.e. is obtained with this new heterogeneous 
catalyst. As shown in Table 5.5, the present system is already as 
enantioselective as its homogeneous analogue ( 95.7% vs. 96.1% ). 
Recycling of the used catalyst is possible without any loss in 
en an tioselecti vi ty. 
Using the new formulation, a self-assembly test was again carried 
out to test the long-term stability of the catalyst. 1x1o-7 mole of the 
ruthenium complex in 50 f.ll of ethylene glycol was mixed with 4x1o-6 
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moles of substrate 1 in 5 ml of 1:1 chloroform/ cyclohexane. 0.2g of CPG-240 
were added, then the reactor pressurized to 1,400 psig with hydrogen and 
then stirred at room temperature for 2 hours. Complete conversion was 
observed. However, less than 2% conversion was found from the control 
experiment where no CPG was added. These results again indicate that, 
under these new reaction conditions, the individual components of the 
present catalytic system self-assemble into the more stable supported-
catalyst configuration. 
As shown by the data in Table 5.2, the new heterogeneous catalyst 
activated by method B is slightly less reactive than the in-situ activated 
analogue ( 40.7 hr-1 vs. 54.2 hr-1 ). However, it is still only 2.5 times less 
active than its homogeneous counterpart in neat ethylene glycol. In 
principle, the catalyst activated by procedure B should be able to attain the 
same high activity as the in-situ activated analogue by using an 
impregnating solvent with higher content of ethylene glycol. As ethylene 
glycol will form two phases with ethyl acetate, there exists a certain upper 
limit for the ethylene glycol content in ethyl acetate. Therefore, it will be 
more desirable to have an impregnating solvent miscible with ethylene 
glycol. In this way, higher ethylene glycol content can be reached in a single 
impregnation. Since the ruthenium complex cannot be dissolved in 
acetone, acetone can be used as the impregnating solvent (in place of ethyl 
acetate). After the impregnation, the acetone can easily be removed by 
exposure to vacuum while leaving behind a thin film of ethylene glycol. 
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This type of impregnation method will allow for a fairly quantitative 
deposition of ethylene glycol onto the CPG support. 
With comparable activity and enantioselectivity to the 
homogeneous catalyst, the present heterogeneous catalyst can be 
considered as a genuine hybrid of homogeneous and heterogeneous 
catalysts. As compared to the asymmetric hydrogenation catalysts anchored 
in modified USY zeolites (7,8), our system has several distinguishing 
features. The CPG support possesses large and uniform pore diameters that 
allow large bio-substrates access to the catalytic sites. Also, CPG supports are 
commercially available in a wide range of pore diameters ( 75 - 3000A ); for 
the zeolite-supported catalyst (7), the small pore size ( -8A) limits the size 
of substrates. Furthermore, the active rhodium complex is covalently 
bonded to the zeolite framework and reasonable activity can only be 
reached at elevated temperature (60°C). In contrast, the active ruthenium 
complex in the present system is dissolved in ethylene glycol, which is 
immobilized as a thin film on the CPG support. At molecular level, this 
method of immobilization yields a heterogeneous catalyst that is basically 
the same as its homogeneous analogue, thus allowing for the high 
enantioselectivity and activity. 
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Table 5.1 Homogeneous reduction of substrate 1t 
Solvent e.e. (%) 
MeOH 88.2 
1:1 MeOH/ HOCH2CH20H 
HOCH2CH20H 




t: substrate/ ruthenium= 100; 1350-1450 psig of 
hydrogen and at room temperature 
#: ref. 1 
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Table 5.2 Activities of various catalytic systems in the 
reduction of substrate 1 * 
Catalyst Solvent t.o.f. (hr-1) 
Homogeneous# MeOH 131.0 
Homogeneous HOCHzCHzOH 103.4 
Two-phase HOCHzCHzOH/ AcOEt 15.3 
Two-phase# HzO/AcOEt 0.34 
Heterogeneous t AcOEt 54.2 
Heterogeneous+ 1:1 CHCl3/Cyclohexane 40.7 
SAP (hydrated)# AcOEt 18.2 
*· substrate/ruthenium= 30-100; H2 pressure= 1350-1450 psig; 





in-situ catalyst activation with method (A) 
catalyst activation with method (B) and reaction carried 
out in 1:1 chloroform/ cyclohexane 
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Table 5.3 Enantioselectivities in the reduction of substrate 1 as 
a function of ethylene glycol content in the 
organic phase t 









t: catalysts were activated by in-situ organic-phase impregnation 
with 5 ml of ethyl acetate; substrate/ruthenium = 30; pressure 
= 1400 psig and at room temperature 
a: with addition of triethylamine 
b: reaction temperature = 3°C 
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Table 5.4 Ruthenium leaching as a function of ethylene glycol 
content in the reduction of substrate 1 * 












substrate/ruthenium= 30; H2 pressure= 1350-1450 psig; 
reaction temp. = 24°C; stirring speed= 350 rpm 
in-situ catalyst activation with method (A) 
ruthenium content in the reaction filtrates 
reaction temperature= 3°C 
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Table 5.5 Enantioselectivities in the reduction of substrate 1 
with ruthenium catalysts in different configurations* 
Catalyst Solvent e.e. (%) 
Heterogeneous+ 1:1 CHCl3/Cyclohexane 88.4 
Heterogeneous+ 1:1 CHCl3/Cyclohexane 95.7a 
Heterogeneous t AcOEt 87.7 
Heterogeneous t AcOEt 94.8a 
Homogeneous# MeOH 88.2 
Homogeneous# MeOH 96.1b 
*· substrate/ ruthenium= 30-100; H2 pressure= 1350-1450 psig; 






catalysts activation with method (B) 
in-situ catalyst activation with method (A) 
ref. 1 
reaction temperature = 3°C 
reaction temperature = 4°C in ref. 1 
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In this work, a water-soluble analogue of BINAP was synthesized. A 
rhodium complex of this ligand was found to be the first water-soluble 
catalyst to exhibit higher enantioselectivities in the reduction of 2-acylamino 
acid precursors in neat water than in other alcoholic solvents. More 
importantly, the e.e. obtained in neat water is as high as that of the non-
sulfonated Rh-BINAP system in organic media. Additionally, the presence of 
four bulky sulfonate groups results in an enantioselectivity that is 
independent of the substrate concentration. 
The versatility of this new water-soluble ligand was further enhanced 
by the preparation of the first reported ruthenium (II) sulfonated chiral 
diphosphine complex. Because of a wider range of substrates that can be 
converted at high e .e. 's, the ruthenium sulfonated-BINAP system greatly 
expands the use of asymmetric catalysis by water-soluble organometallic 
complexes. Being more stable than the rhodium analogue, the ruthenium 
complex was used in the fabrication of the asymmetric version of the 
supported aqueous-phase catalyst. Both the activity and the enantioselectivity 
of the hydrated SAP catalyst are dependent on the water content. These 
results suggest that the mobility of the active organometallic complex on the 
surface of the CPG support is critical to the overall performance of the SAP 
catalyst. 
During the progress of this work, it was found that the aquation of 
ruthenium-chloro bond in water was detrimental to the enantioselectivity 
with some substrates, and so the performance of the hydrated SAP catalyst 
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was bounded by the intrinsic enantioselectivity limit of the ruthenium 
complex in water. Nevertheless, the concept of supported aqueous-phase 
catalysis was proven to be applicable to asymmetric catalysis. 
Replacement of water with anhydrous ethylene glycol was found to 
allow for the retention of the ruthenium-chloro bond and thus the same high 
level of enantioselectivity was obtained in the reduction of 2-(6'-methoxy-2'-
naphthyl)acrylic acid (1) either in neat methanol, neat ethylene glycol or 1:1 
mixture of methanol and ethylene glycol. Through a modification in the 
composition of the original hydrated SAP catalyst, a new generation of 
heterogeneous catalyst was prepared. Anhydrous ethylene glycol was used in 
place of water as the hydrophilic film that was supported on the CPG, and a 
hydrophobic solvent immiscible with the components of the supported film 
was used as the bulk organic phase (1:1 v /v mixture of chloroform and 
cyclohexane). The asymmetric reduction of 2-(6'-methoxy-2'-naphthyl)acrylic 
acid (1) to the commercially important, non-steroidal, anti-inflammatory 
agent, naproxen was used to illustrate the efficacy of this new catalyst. The 
reaction proceeds over the catalyst at one-third of the rate observed in 
homogeneous solution and gives an 96% e.e. with no leaching of the 
organometallic complex into the bulk organic phase at a detection limit of 32 
ppb. The long-term stability of this new catalyst composition was proven by a 
self-assembly test. 
One of the unique features of this new heterogeneous, asymmetric 
catalyst, which is also one of the reasons for its success, is the method of 
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immobilization. Rather than immobilizing the active organometallic complex 
through a covalent bond to a supporting surface; which usually leads to a 
significant loss in activity, here the hydrophilic phase containing the 
organometallic complex and ethylene glycol is immobilized onto the support. 
At molecular level, this method of immobilization yields a heterogeneous 
catalyst that is basically the same as its homogeneous analogue, thus allowing 
for high enantioselectivity and activity. 
By successful implementation of prescribed steps, a true, 
heterogeneous, asymmetric catalyst with high enantioselectivity and activity 
was developed. The strategies outlined here are general, and can hopefully be 
applied to the development of other heterogeneous, asymmetric catalysts. 
